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acute	 and	 chronic	 conditions.	 	 The	 capacity	 for	 NHS	 services	 to	 meet	 these	
demands	 is	 limited	 and	 therefore	 care	 homes	 provide	 accommodation	 and	
health	 services	 to	 meet	 this	 unmet	 need.	 In	 the	 lay	 press,	 there	 have	 been	
concerns	 regarding	 medication	 management	 in	 care	 homes	 and	 there	 is	
evidence	in	the	literature	that	this	process	is	sub-optimal.	The	aim	of	this	thesis	
therefore	was	to	explore	medicines	management	in	care	homes	focusing	on	the	
areas	 of	 prescribing,	 administration	 and	 medicines	 waste.	 A	 retrospective	
analysis	of	anonymised	medication	administration	records	(MAR	charts)	and	an	
audit	 of	 medicines	 waste	 was	 employed	 to	 achieve	 this	 aim.	 The	 analysis	
revealed	 that	 a	 significant	 number	 of	 residents	 (84%)	 were	 exposed	 to	
polypharmacy,	 potentially	 inappropriate	 medications	 (87%),	 anticholinergic	
burden	(5%	with	an	AEC	score	³	5),	and	a	significant	number	of	administration	
errors	 (6	 administration	 errors	 per	 resident	 per	 week).	 The	 study	 also	
demonstrated	 a	 significant	 volume	 of	wasted	medicines	 in	 care	 homes.	 As	 a	
consequence	of	these	issues	residents	in	care	homes	are	potentially	exposed	to	
practices	that	may	lead	to	harm	and	will	likely	increase	the	demand	on	health	
and	 social	 care	 resources.	 Careful	 consideration	 of	 prescribing	 practices	 is	
needed	 to	 reduce	medicines	burden	and	efforts	 should	be	made	 to	embed	a	
multidisciplinary	approach	to	the	care	residents.	In	conclusion,	further	study	of	
the	clinical	 consequences	of	prescribing	and	medication	errors	 in	care	homes	



















































































































































































































Table 2.17 number of residents prescribed medicines with a cumulative AEC Score of 





































































In	the	United	Kingdom,	 institutional	 long-term	care	for	older	adults	 is	principally	





Act	 2000	Part	 1	 Section	3,	 the	Department	of	Health	 states	 “a	 care	home	 is	 an	











provides	 residential	 care,	 not	 including	 nursing,	 for	 disabled	 or	 elderly	 infirm	
people	 including	 the	 elderly	mentally	 ill"	 (Heath	 2006),	 whilst	 nursing	 homes	
were	defined	as	"An	establishment	which	provides	residential	and	nursing	care	
for	sick,	disabled	or	elderly	infirm	people,	including	the	elderly	mentally	ill	...	run	














Increasingly	 care	 homes	 are	 adopting	 a	 mixed	 approach	 and	 provide	 both	
residential	and	nursing	places.	If	a	care	home	has	different	‘wings’	or	‘wards’	for	
nursing	and	personal	care	that	together	form	one	registered	premise,	the	entire	




dementia)	 and	 a	 number	 of	 care	 homes	provide	 specialist	 care	 for	 particular	
patient	 cohorts	 such	 as	 those	 requiring	 palliative	 care	 	 (Centre	 for	 Policy	 on	

















number	 of	 beds	 available	 in	 secondary	 care	 (10,934	 beds)	 (Smith	 2017).		
Ownership	is	distributed	between	local	authorities,	 larger	group	providers	(15	
groups	with	4	or	more	care	homes),	smaller	group	providers	(51	groups	with	2	
or	 3	 care	 homes)	 and	 single	 home	 providers	 (363	 providers).	 Larger	 group	
providers	 tend	 to	 operate	 homes	 with	 higher	 numbers	 of	 beds	 than	 other	
operators	(see	Table	1.1).			



































































































effective	 use	 of	 medicines	 by	 care	 home	 residents.	 The	 outcome	 essentially	


















9.2	 The	 service	user,	 following	assessment	as	able	 to	 self-administer	medication,	has	a	
lockable	space	in	which	to	store	medication,	to	which	suitably	trained,	designated	care	
staff	may	have	access	with	the	service	user’s	permission.	






















9.9	 The	 registered	manager	 seeks	 information	and	advice	 from	a	pharmacist	 regarding	















and	 high-quality	 care	 to	 their	 service	 users	 according	 to	 legislative	 and	
regulatory	 requirements.	 CIW	 regulate	 and	 inspect	 a	 variety	 of	 care	 settings.	
These	include	(i)	care	homes	which	provide	services	for	both	children	and	adults;	
(ii)	 domiciliary	 support	 service	 that	 provide	 home	 care;	 (iii)	 adult	 placement	
schemes;	(iv)	child	minders;	(v)	children’s	day	care;	(vi)	 independent	fostering	





range	 of	 actions	 including	 issuing	 non-compliance	 notices,	 cancelling	 the	































Health	Social	 Services	and	Public	 Safety	2015).	 	 In	 residential	 care	homes	 i.e.	



























of	 care.	 This	 	 includes	working	with	 primary	 and	 community	 care	 services	 to	
ensure	 appropriate	 management	 of	 the	 health	 needs	 of	 residents	 and	 to	
minimise	the	risk	of	unnecessary	hospital	admissions(	NICE	2014;	NICE	2015).	
Ensuring	 older	 people	 can	 access	 high	 quality	 nursing	 care	 in	 care	 homes	 is	














comparing	 the	outcomes	of	care	 interventions	delivered	by	 registered	nurses	
(RNs)	with	those	of	care	assistants	in	nursing	homes	for	older	people	in	the	UK.	
The	study	concluded	that	the	RNs	role	is	broad	and	multifunctional	in	the	care	













People	 who	 live	 in	 care	 homes	 are	 commonly	 described	 as	 service	 users,	
residents	or	clients;	the	term	‘resident’	will	be	used	throughout	this	thesis.	Such	
residents	have	always	varied	in	terms	of	their	health	needs	however,	in	the	past	














more	 clinical	 diagnoses,	 taking	 seven	 or	 more	 medications,	 and	 living	 with	





from	 ‘Geriatric	 Syndrome’	 (Won	 et	 al.	 2013)	 a	 broad	 definition	 of	 clinical	
conditions	 such	 as	 delirium,	 falls,	 frailty,	 dizziness,	 syncope	 and	 urinary	
incontinence.	 Combined,	 these	 syndromes	 have	 a	 significant	 impact	 on	 a	
resident	quality	of	 life	and	result	 in	high	levels	of	disability	(see	Chapter	2	 for	










impairment	 (NHS	 England	 2016a).	 	 Dementia	 is	 one	 of	 the	 major	 causes	 of	
cognitive	 impairment	 and	 although	 there	 is	 a	 spectrum	 of	 dementias,	
Alzheimer's	 disease	 has	 been	 reported	 to	 be	 the	 most	 common	 cause	 of	
progressive	 dementia	 in	 care	 homes	 (comprising	 62%	 of	 all	 residents	 with	
dementia)	 followed	by	dementia	 related	to	vascular	causes	 (27%	of	 residents	
with	 dementia)	 (The	 Alzheimer's	 Society	 demographics	 and	 statistics,	 2013).	
Dementia	 is	 associated	with	 behavioral	 and	 psychological	 symptoms	 such	 as	
changes	 in	 mood,	 memory	 loss,	 apathy,	 confusion,	 anxiety,	 and	 difficulty	 in	
finding	the	right	words	and	progressive	difficulty	with	task	that	need	planning.	
These	 symptoms	 generally	 result	 in	 a	 reduced	quality	 of	 life	 and	 impede	 the	
















admission	were	older	age,	biological	sex	 (women),	 reduced	 levels	of	Personal	
and	Instrumental	Activities	of	Daily	Living,	cognitive	impairment,	living	alone	and	

























complementary	 and	 alternative	 medicines;	 these	 are	 often	 provided	 by	 the	
resident’s	relatives	(Duerden	M	2013).		
The	 consequences	 of	 polypharmacy	 and	 inappropriate	 prescribing	 in	 older	
adults	in	primary	and	secondary	care	settings	is	well	established	(Maher	et	al.	
2014).	 For	 example,	polypharmacy	has	been	 shown	 to	be	associated	with	an	
increased	risk	of	adverse	drug	events	(ADEs)	in	older	adults	and	is	responsible	
for	up	 to	12%	of	all	hospitalisations	 in	 the	elderly	population	 (Parameswaran	
Nair	et	al.	2016).	 It	also	has	an	 impact	on	medicines	adherence	rates	 in	older	
adults	which	 has	 been	 shown	 to	 be	 directly	 proportionate	 to	 the	 number	 of	






















medicines	 related	 activities	 prior	 to	 the	 medicine	 reaching	 the	 resident	 and	




by	 relevant	 professional	 bodies	 such	 as	 the	 General	 Medical	 Council	 (GMC)	
(2013)	and	the	General	Pharmaceutical	Council	(GPhC)	(2015).	Prescribing	is	a	





• Prescribing	 decision	 making	 supported	 by	 evidence	 based	 clinical	
guidance	(local	and/or	national)	
• Potential	adverse	reactions	to	drugs	are	recognised	and	mitigated	
• Potential	 drug-drug	 interactions	 are	 recognised	 and	 addressed	 (Royal	
Pharmaceutical	Society	2014)		
	 	
Any	 failure	 to	 address	 these	 key	 aspects	 may	 ultimately	 lead	 to	 potentially	
inappropriate	 prescribing	 (PIP).	 	 The	 term	 ‘inappropriate	 prescribing’	 broadly	
covers	 three	activities:	 (i)	over-prescribing	 (prescribing	a	drug	without	a	valid	
indication);	 (ii)	 miss-prescribing	 (incorrectly	 prescribing	 a	 drug	 for	 a	 valid	
indication)	 and	 (iii)	 under-prescribing	 ‘failure	 to	 prescribe	 an	 indicated	 drug’	
(Anrys	et	al.	2015).	
	
The	majority	 of	 care	 homes	 are	 serviced	by	more	 than	one	 general	 practice.	
Traditionally,	the	General	Practitioner	(GP)	that	an	individual	is	registered	with	
remains	 responsible	 for	 their	medical	 care	 (including	 prescribing)	 when	 they	




other	 practitioners	 including	 secondary	 care	 doctors	 (as	 a	 consequence	 of	 a	




Critically,	 quality	 of	 prescribing	 is	 an	 important	 determinant	 of	wellbeing	 for	
older	adults	with	inappropriate	or	excessive	use	of	medicines	shown	to	increase	
mortality,	 hospital	 admission,	 falls,	 functional	 impairment,	 and	 cognitive	
decline.	For	example,	Ruggiero	and	colleagues	found	that	care	home	residents	
receiving	two	or	more	potentially	inappropriate	medications	(PIMs)	had	a	75%	
higher	 risk	 of	 being	 hospitalised,	 (hazard	 ratio	 [HR]	 1.73;	 95%	 CI	 1.14,	 2.60),	
during	a	12-month	follow	up	period	(Ruggiero	et	al.	2010).	Similarly,	Klarin	and	




The	prevalence	of	potentially	 inappropriate	prescribing	 (PIP)	 in	care	homes	 is	
reasonably	well	documented	but	varies	depending	on	the	study.	In	their	seminal	
systematic	review,	Morin	and	colleagues	found	the	prevalence	of	inappropriate	
prescribing	 ranged	 from	 27%	 in	 the	 USA	 to	 nearly	 50%	 in	 some	 European	
countries	(Morin	et	al.	2016).	In	England	and	Wales	nearly	30%	of	all	residents	
in	care	homes	have	been	prescribed	at	least	one	PIM;	most	commonly	this	was	
an	 antipsychotic	 or	 anticholinergic	 (Shah	 et	 al.	 2012).	 Of	 note,	 Cox	 and	
colleagues	 identified	 a	 3-fold	 increase	 in	 the	 rate	 of	 falls	 in	 nursing	 home	
residents	 who	 were	 prescribed	 an	 antipsychotic	 and	 antidepressant	 drugs.	
(Hartikainen	et	al.	2007;	Cox	et	al.	2016).		
In	addition,	inappropriate	prescribing	has	been	shown	to	lead	to	an	increase	in	










to	 a	 single	 community	 pharmacy.	 Towards	 the	 end	 of	 a	medicines	 cycle	 (28	
days),	staff	 in	the	care	home	will	order	medicines	for	the	next	cycle	from	the	
community	 pharmacy.	 The	 community	 pharmacy	 then	 requests	 the	
prescriptions	 from	the	relevant	GP	practice(s).	On	receipt	of	 the	prescription,	






care	homes:	 (i)	 in	 individual	packs,	 labelled	with	 resident’s	name	and	dosage	
details	or	(ii)	using	monitored	dosage	systems	(MDS).		This	depends	on	both	the	
request	 of	 the	 care	 home	 manager	 or	 owner,	 and	 whether	 the	 community	
pharmacy	 to	which	 they	 are	 registered	 offers	 an	MDS	 service	 (Alldred	 et	 al.	
2009).		
1.4.1.3 Monitored	Dosage	Systems		
MDS	 is	 a	 storage	 device	 for	 solid	 medications	 aimed	 at	 simplifying	 the	
administration	of	medication	by	or	to	patients	/	residents.	It	is	a	type	of	Multi-
Compartment	 Compliance	 Aid	 (MCA).	 They	 are	 usually	 filled	 at	 the	 point	 of	
dispensing	 in	a	pharmacy	and	can	be	particularly	useful	 in	care	homes	where	
medication	 is	 administered	 to	 a	 large	 number	 of	 residents.	 MDS	 has	 been	
reported	 to	have	a	number	of	benefits	 including	enhancing	 the	adherence	of	
residents	to	a	medication	regimen	and		minimising	errors	related	to	the	dose	of	




however.	 In	 general,	 the	 system	 is	 only	 suitable	 for	 oral	 solid	 medications	
although	there	are	specialist	systems	(e.g.	Biodose)	that	allows	for	liquid	dosage	
forms.	 However	 none	 of	 the	 systems	 are	 suitable	 for	 ‘when	 required’	
medications.	Estimates	suggest	that	approximately	40%	of	all	medicines	in	a	care	
home	 are	 packaged	 in	 MDS	 systems	 (Alldred	 et	 al.	 2009).	 The	 Royal	
Pharmaceutical	 Society	 state	 that	 MDS	 is	 not	 recommended	 for	 some	
medications	including	on	demand	medication,	drugs	with	potential	cytotoxicity,	
drugs	with	variable	dosing	and	hygroscopic	or	photosensitive	drugs	(Pountney	
2010).	 Nevertheless,	 MDS	 remains	 the	 most	 common	 system	 used	 in	 Care	
Homes	for	medicines	management.		
1.4.1.4 The	medication	administration	process	in	care	homes	




Generally,	 one	 member	 of	 staff	 will	 conduct	 the	 drug	 administration	 round	
which	can	take	anywhere	between	30	minutes	to	two	hours	depending	on	the	
number	 of	 residents	 and	 number	 of	 medications	 administered	 in	 each	 care	
home	(Alldred	et	al.	2009).	
Medicines	administration	in	the	care	home	setting	has	become	more	complex	in	
the	 past	 40	 years	 as	 a	 result	 of	 the	 increasing	 number	 of	 drugs	 and	 routes	
available	to	treat	residents	who	have	 increasingly	complex	conditions	and	co-
morbidities.	Medications	are	supplied	by	different	drug	companies	and	can	have	














of	 medicines,	 by	 means	 of	 making	 appropriate	 arrangements	 for	 the	








medicine	 being	 prescribed	 made	 available	 to	 them	 or	 others	
acting	on	their	behalf.		
	
In	 turn	 this	 means	 providers	 “must	 handle	 medicines	 safely,	 securely	 and	
appropriately,	ensure	that	medicines	are	prescribed	and	given	by	people	safely	
and	 follow	 published	 guidance	 about	 how	 to	 use	 medicines	 safely.”					
(Oxfordshire	Clinical	Commissioning	Group	2015).	
A	 number	 of	 professional	 organisations	 have	 recognised	 the	 issues	 that	 can	
occur	in	care	homes	during	medicines	administration	rounds	and	have	produced	
corresponding	guidelines	 (Centre	 for	Policy	on	Aging	2011).	 For	example,	 the	
Royal	 Pharmaceutical	 Society	 has	 published	 a	 variety	 of	 guidelines	 including	
‘Improving	Pharmaceutical	Care	in	Care	Homes’	(Royal	Pharmaceutical	Society	
in	Scotland	2012),	 ‘Improving	Medicines	Use	for	Care	Home	Residents’	 (Royal	






medicines.	 The	 key	 points	 in	 these	 documents	 were:	 (i)	 the	 need	 to	 deliver	
personalised		pharmaceutical	care	to	care	home	residents	based	on	individual	



















and	 service	providers	 regularly	 review	and	audit	 their	policies,	processes	and	
local	governance	arrangements	to	guarantee	quality	system	are	in	place	in	care	
homes.	Further,	they	ensure	clear	lines	of	accountability	and	responsibility	in	the	
effective	management	 and	 administration	 of	medicines	 in	 care	 homes	 (NICE	
2014).	
1.5 Medicines	administration	errors	
Despite	 policies	 and	 procedures	 that	 seek	 to	 regulate,	 and	 quality	 assure	







CHUMS	 study.	 In	 this	 study,	 the	 investigators	 reviewed	 the	 medicines	
administration	 process	 in	 55	 care	 homes	 in	 England.	 Two	 drug	 rounds	 were	
observed	 for	 each	 of	 the	 256	 residents	 included	 in	 the	 study.	 	 The	 authors	
determined	 that	 care	 home	 staff	 spend	 as	much	 as	 40-50%	of	 their	 time	 on	
activities	that	are	related	to	medicines	administration	and	that	errors	occur	in	
8.4%	of	 all	 administrations	per	medication	 round.	 The	 authors	 also	observed	
that	~70%	of	residents	were	exposed	to	at	least	one	medication	error	per	day.		
Of	 the	 errors	 observed,	 approximately	 50%	were	 dose	 ‘omissions’	 and	more	
than	20%	were	incorrect	doses.	The	areas	identified	for	“priority	attention”	in	
the	 report	 included	 the	 Medication	 Administration	 Record	 (MAR)	 chart,	 the	
medication	 round	 itself	 and	 in	 particular	 dealing	 with	 interruptions	 and	
distractions,	as	well	as	improving	lines	of	communication	between	the	medicine	
provider	(generally	a	pharmacy)	and	care	home	staff	(Alldred	et	al.	2009).		
The	 CHUMS	 study	 is	 by	 no	 means	 the	 only	 example	 of	 poor	 medicines	
management	 in	care	homes.	Szczepura	et	al,	 (2011),	undertook	a	prospective	








the	 staff	 involved	 in	 administering	 medicines	 (12/41)	 were	 aware	 of	 the	
potential	for	error	in	their	care	homes.	In	those	who	recognized	the	potential	for	





indicated	 they	 were	 “'stressed'	 or	 'under	 pressure	 to	 complete	 the	 round'”;	
issues	of	stress	and	time	pressures	were	said	to	be	more	prevalent	in	residential	
homes	compared	to	nursing	homes	(Szczepura	et	al.	2011).		
A	 number	 of	 studies	 have	 also	 reported	 on	 the	 impact	 of	 interruptions	 and	
distractions	 on	medicines	 administrations,	 Scott-Cawiezell	 and	 colleagues	 for	
example	have	reported	a	positive	relationship	between	interruptions	and	rate	
of	 administration	 errors	 with	 (p	 <	 0.099)	 through	 observing	 44	 medication	
administration	for	907	residents	in	5	nursing	homes	(Scott-Cawiezell	et	al.	2007).	
Similarly,	Biron	and	colleagues	reported	on	the	rate	of	interruptions	experienced	
by	 nursing	 staff	 during	medicines	 administration	 rounds.	 In	 an	 observational	
study	the	authors	reported	an	overall	interruption	rate	of	6.3	interruptions	per	
hour.	In	the	main	these	distractions	were	from	other	nurse	colleagues	(29.3%)	
or	 as	 a	 result	 of	 ‘system	 failures’	 that	 included	 missing	 medication	 or	
equipment	(22.8%)	during	the	preparation	phase	and	from	self-initiation	e.g.	to	
undertake	 secondary	 tasks	 (16.9%)	 and	 patients	 (16.0%)	 during	 the	
administration	 phase.	 Whilst	 the	 authors	 did	 not	 investigate	 the	 clinical	
consequences	 of	 these	 interruptions,	 they	 indicated	 that	 medicines	




including	 staff	 failing	 to	 supervise	 residents	 taking	 their	medication	 (this	was	
particularly	 concerning	 for	 those	 with	 dementia),	 and	 irregular	 timing	 of	
medicines	administration	with	medications	frequently	administered	more	than	
an	hour	early	or	late	(van	den	Bemt	et	al.	2009).	A	study	in	the	US	by	Pierson	et	
al.	 reported	 on	 the	 implementation	 of	 a	 web-based	 error	 reporting	 system	






made	 related	 to	 2,731	 discrete	 error	 instances.	 The	 most	 common	 errors	
reported	 were	 dose	 omission	 (32%),	 overdose	 (14%),	 under	 dose	 (7%),	
administration	 to	 the	wrong	 patient	 (6%),	 and	wrong	medicine	 administered	
(6%),	and	wrong	strength	of	medicine	administered	(6%).	Most	errors	occurred	
during	 the	administration	round	 itself	 (47%)	and	67%	of	 the	errors	 that	were	
deemed	to	have	the	most	impact	on	patient	health	were	at	the	point	of	patient	




a	 disguised	 observational	 study	 over	 a	 two-week	 period	 but	 limited	 to	
observations	 on	 Monday,	 Wednesday,	 Thursday	 and	 Friday.	 Of	 the	 2,025	
administrations	observed,	errors	were	observed	in	428,	an	error	rate	of	~	21%.	
Staff	 frequently	 failed	 to	 supervise	 residents	 taking	 their	 medications	 and	
medicines	were	often	inappropriately	handled	for	example	enteric	coated	and	
modified	release	formulations	were	frequently	crushed	prior	to	administration	
(van	 den	 Bemt	 et	 al.	 2009).	 Particular	 classes	 of	 drugs	 were	 noted	 to	 be	
problematic,	for	example	patients	prescribed	antibiotics	had	a	higher	risk	of	a	
medicine	administration	error.	A	study	in	care	homes	in	the	county	of	Gwent	in	
South	Wales	 by	 Hussain	 and	Walker	 revealed	 similar	 findings.	 In	 a	 two-year	
period,	 18%	 of	 antibiotic	 regimens	 prescribed	 were	 administered	
inappropriately	(500	of	2,859	courses)	(Hussain	and	Walker	1999).	














in	 the	morning	 round(s)	 or	 whether	 they	 could	 be	moved	 to	 the	 afternoon.	
Where	 a	 prescription	 indicates	 for	 example	 the	 medicine	 should	 be	








administration;	 and	 (iii)	 interventions	 related	 to	 blood	 tests.	 The	 baseline	
analysis	 indicated	 that	 although	 the	 two	 homes	 had	 written	 procedures	 for	
medicines	 administration,	 only	 58%	 of	 all	 administrations	 were	 being	
administered	in	accordance	with	these	guidelines.	The	most	frequent	deviation	
from	the	written	procedures	was	a	failure	to	formally	identify	the	resident	prior	
to	 administration	 and	 recording	 the	 administration	 without	 witnessing	
consumption.	 In	 addition,	 there	 was	 a	 failure	 to	 administer	 medicines	 in	
accordance	with	 the	prescriber’s	 intentions	 in	21.2%	of	 all	 administration	 for	
regular	medications	and	79.2%	of	all	administrations	for	‘when	required’	drugs.	
Of	 note	 2.7%	 and	 18.9%	 of	 administrations	 of	 regular	 and	 ‘when	 required	
medicines’	were	not	recorded	at	all	(Deshmukh	and	Sommerville	1996).	
There	is	 limited	anecdotal	evidence	that	the	landscape	is	similar	 in	Wales,	for	
example	 in	 2006	 the	 national	 service	 framework	 for	 older	 people	 in	 Wales	




hospitals	 and	 care	 homes.	 The	 report	 stated	 that	 “administration	 errors	
especially	 non-administration	 occur	 relatively	 frequently	 both	 in	 hospital	 and	
care	settings”	 (Welsh	Assembly	Government	2006).	However,	no	quantitative	
data	was	provided.	To	date	then,	there	has	been	little	work	examining	the	scale	
of	 the	 issues	 in	 Care	 Homes	 in	 Wales.	 To	 guard	 against	 medication	 errors,	
regulations	 and	 national	 minimum	 standards	 	 have	 been	 established	 in	
Wales(Welsh	Assembly	Government	2004)	and	in	England(CQC	2016)	to	help	to	
improve	 the	 quality	 of	medicines	management	 in	 care	 homes.	 Nevertheless,	
care	homes	continue	to	have	difficulties	in	achieving	a	satisfactory	performance	
in	medicines	management.	The	CQC	in	England	for	example	reported	that	nearly	
30%	 of	 care	 homes	 in	 England	 failed	 to	 meet	 the	 standards	 on	 medicines	
management	in	2015-16	(CQC	2016).		
Identifying	the	root	causes	of	medication	errors	in	Care	Homes	is	an	important	
and	 necessary	 step	 in	 establishing	 solutions	 to	 the	 problem.	 However,	 the	
evidence	is	equivocal,	and	it	has	been	difficult	to	determine	the	primary	cause(s)	
of	medication	errors	in	care	homes.	This	has	been	as	a	consequence	of	a	number	
of	 factors	 not	 least	 a	 general	 lack	 of	 research	 in	 the	 care	 home	 setting	 and	
varying	methodological	approaches	to	identify	medication	errors.	Nevertheless,	
a	number	of	causative	factors	have	been	identified.	For	instance,	in	the	CHUMs	
study,	 staff	 workload,	 lack	 of	 medicines	 training,	 interruptions	 during	
administration	rounds	together	with	a	lack	of	team	work	between	health	care	
professionals	were	factors	cited	as	contributors	to	medicine	errors	(Alldred	et	al.	
2009).	 Other	 studies	 have	 highlighted	 that	 the	 appropriate	 education	 and	
training	 of	 staff	 is	 key	 in	 ensuring	 appropriate	 care	 for	 residents	 with	 staff	
discussion	and	problem-solving	activities	leading	to	positive	outcomes	without	
necessarily	the	need	for	a	formal	educational	programme.	(Nolan	et	al.	2008)	







Interruptions	during	 the	administration	process	 is	 also	acknowledged	 to	be	a	
cause	of	administration	errors	impacting	on	the	efficiency,	quality,	and	safety	of	
administration	 processes	 (Thomson	 et	 al.	 2009).	 The	 literature	 broadly	
distinguishes	 between	 three	 types	 of	 interruption:	 interruptions	 mid	 task,	
interruptions	between	tasks,	and	system	failures	(e.g.	poor	access	to	equipment	
and	supplies)	(	King's	College	London	2010).	
Ultimately,	 irrespective	 of	 the	 cause	 of	 medicines	 related	 errors	 in	 the	 care	
home,	they	have	the	capacity	to	result	in	significant	harm	to	the	resident.	Such	
harm	 may	 increase	 the	 risk	 of	 an	 unintended	 health	 intervention,	 hospital	





the	NHS	 (NHS	England	2016b),	 reducing	 the	 financial	 burden	associated	with	
ineffective	medicines	management	is	a	priority.		
1.6 Scope	of	thesis	







functions	 of	 care	 homes	 is	 to	 support	 residents	 to	 take	 their	 medicines	











prescribed)	 (Jiron	 et	 al.	 2015)	 and	 excessive	 polypharmacy	 (>10	 medicines	
prescribed)	 was	 evaluated	 for	 each	 resident	 and	 the	 number	 of	 residents	




by	 therapeutic	 class	was	 evaluated	 to	 provide	 an	 overview	 of	 the	medicines	
prescribed	to	care	home	residents.		
Chapter	 3	 builds	 on	 the	 findings	 in	 Chapter	 2	 by	 exploring	 the	 quality	 of	
medicines	management	in	home	residents	using	the	same	MAR	charts	that	were	
used	 in	 Chapter	 2.	 Errors	 were	 classified	 into	 five	 primary	 categories:	
administration,	 MAR	 chart	 errors,	 stock	 errors,	 regulatory	 errors	 and	
miscellaneous	errors	that	could	not	be	fully	categorised	based	on	MAR	charts	
alone.	A	particular	 focus	of	 the	 study	was	on	administration	errors	 i.e.	doses	
omitted,	 extra	 doses	 given,	 a	 deviation	 from	 the	 prescribed	 dose,	 an	
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life	 expectancy,	 in	 both	 developed	 and	 developing	 countries,	 the	 older	 adult	











	 2010	 2020	 2030	 2040	 2050	
Developed	countries	[people	in	millions]	
Total	population	 1,365,899	 1,397,353	 1,411,479	 1,412,224	 1,402,753	
Population	³	65	years	 204,140	 248,215	 298,215	 327,122	 343,396	
%	of	total	population	 14.9	 17.8	 21.1	 23.2	 24.5	
Developing	countries	[people	in	millions]	
Total	population	 5,539,491	 6,267,938	 6,903,864	 7,408,412	 7,785,103	
Population	³	65	years	 323,716	 467,255	 671,557	 919,185	 1,122,963	
%	of	total	population	 5.8	 7.5	 9.7	 12.4	 14.4	
This	 dramatic	 shift	 in	 the	 population	 is	 predicted	 to	 place	 extra	 pressure	 on	





Figure	 2.1)	 These	 factors	 are	 likely	 to	 place	 significant	 burden	 on	 an	 already	




healthcare	 to	 such	 individuals	 	 (Bonaga	 et	 al.	 2018).	 In	 addition,	 there	 is	 an	
ongoing	trend	to	develop	more	complex	therapeutic	modalities	and	advanced	
formulations	 to	 treat	 a	 range	 of	 emerging	 and	 complex	 conditions	 including	







Aging	 is	 a	gradual	progressive	process	 characterised	by	physiological	 changes	
and	an	observable	decline	 in	body	 functions	 together	with	an	 increase	 in	 the	








aging	 along	with	 the	 consequence	 of	 such	 changes	 on	 pharmacokinetics	 are	
shown	 in	 Table	 2.2	 (adapted	 from	 (Stegemann	 et	 al.	 2010)).	 These	 changes	
impact	the	absorption,	metabolism,	distribution	and	elimination	of	drugs	which	
can	 be	 unpredictable	 and	 subject	 to	 significant	 inter-	 and	 intra-	 patient	
variability	but	ultimately	may	lead	to	adverse	drug	reactions	(Stegemann	et	al.	












Increased	 volume	 of	 distribution	 and	 half-life	 of	
lipophilic	drugs	
• Decreased	total	water	 Increased	 plasma	 concentration	 of	 hydrophilic	
drugs	












can	 be	 less	 effective	 compared	 to	 younger	 adults	 due	 to	 a	 decrease	 in	 the	









categorised	 as	 geriatric	 syndromes.	 Although	 there	 is	 no	 global	 consensus	
defining	the	range	of	geriatric	syndromes	(Won	et	al.	2013),	the	most	commonly	
cited	 syndromes	 are	 frailty,	 falls,	 urinary	 incontinence,	 osteoporosis,	
unintentional	weight	loss,	sleep	disturbances,	delirium,	dementia	and	cognitive	












considered	one	of	 the	most	 effective	 intervention	 to	 reduce	both	 the	
incidence	of	delirium	rate	and	the	resultant	hospital	costs.		
(ii) Falls	 represent	 a	 life-threatening	 issue	 that	 affects	more	 than	 30%	 of	
older	adults	(Inouye	et	al.	2007).	It	can	result	in	an	unintended	hospital	




environment.	 	 A	 number	 of	 educational	 interventions	 have	 been	
conducted	 to	 reduce	 the	 risk	 of	 falls	 including	 raising	 falls	 awareness	
among	older	adults	using	media,	brochures,	 lectures	etc.	 and	 through	












the	main	 type.	 Dementia	 is	 associated	with	 a	 decline	 in	memory	 and	
cognition	and	can	affect	an	individual’s	ability	to	perform	normal	tasks.	
There	are	broadly	 two	 types	of	 interventions	 to	ameliorate	dementia,	
and	 these	 are	 (i)	 non-pharmacological	 interventions	 such	 as	 Cognitive	




Sobeski	2013).	 It	may	occur	due	 to	age-related	changes	 in	 the	urinary	
tract,	 urinary	 infections	 or	 other	 unrelated	 causes	 such	 as	 cancer,	








socioeconomic	 status,	 certain	medications,	 acute	 and	 chronic	medical	
conditions	 (e.g.	 heart	 disease,	 persistent	 cough	 and	 depression).	
Interventions	such	as	improving	sleep	hygiene	and	avoiding	stimuli	are	
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preferred	 to	 pharmacological	 interventions	 (Sagayadevan	 et	 al.	 2017;	
Suzuki	et	al.	2017).	
(vii) Osteoporosis	 is	 a	 progressive	disease	 that	 affects	 nearly	 42%	of	 older	
adults	 in	 the	 UK,	 causing	 bone	 fragility	 that	 can	 result	 in	 debilitating	
fractures	 (National	 Osteoporosis	 Society	 2015).	 It	 is	 characterised	 by	
decreased	bone	mass	and	therefore	 it	should	be	mandatory	for	adults	
over	70	years	of	age	to	have	a	bone	mass	density	test.	Increased	calcium	
and	 vitamin	 D	 supplements	 are	 effective	 intervention	 to	 prevent	
osteoporotic	 fractures	 in	 addition	 to	 weight-bearing	 and	 strength	
training	exercises	(Daware	2014).	
(viii) Unintentional	weight	 loss	 (>	 5%	of	 body	mass	 loss	 in	 the	 last	 year)	 is	
another	 common	 problem	 that	 affects	 older	 adults	 and	 may	 lead	 to	
weakness,	falls,	and	other	health	issues.	It	 is	reported	to	affect	13%	of	
the	older	adult	population	(Ruscin	et	al.	2005).	Diminished	sense	of	taste	
is	 one	 of	 the	 main	 causes	 however,	 medications	 and	 other	 medical	
conditions	also	contribute.	Limited	evidence	is	available	on	the	beneficial	
effect	 of	 either	 nutritional	 or	 pharmacological	 interventions	 on	
improving	weight	in	the	frail	older	adult	population	(Stajkovic	et	al	2011).	
Many	of	these	syndromes	overlap	or	are	a	causative	factor	of	each	other	and	as	
a	 consequence	of	geriatric	 syndromes,	older	adults	are	 likely	be	prescribed	a	







improve	 the	 quality	 of	 life	 of	 individuals.	 Given	 the	 age-related	 changes	 in	
pharmacokinetics	 and	 pharmacodynamics	 in	 this	 population,	 this	 makes	 the	
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medicines	being	prescribed	 rather	 than	 the	absolute	number	 (see	Table	2.4).	
Here,	 polypharmacy	 is	 either	 described	 as	 appropriate	 polypharmacy	
“medication	used	to	treat	complex	or	multiple	conditions	where	medicines	have	
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to	 be	 optimised	 or	 prescribed	 according	 to	 best	 evidence”	 and	 problematic	











• Polypharmacy	definition	 ranges	 from	the	use	of	a	 large	
number	 of	 medications,	 to	 the	 use	 of	 potentially	































Optimisation	 of	 medications	 for	 patients	 with	 complex	










Rational	 polypharmacy	 recognizes	 legitimate	 prescribing	
and	 indiscriminate	 prescribing	 suggests	 inappropriate	















indicate	 that	 ‘extraordinary	 prescribing’	 defines	 “patients	 who	 are	 taking	
medications	that	are	either	grossly	excessive	or	not	beneficial	for	that	patient”	






be	described	as	subject	 to	polypharmacy	 for	example	 if	 they	are	 taking	more	
than	 five	medications.	 However,	 the	 prescribing	may	 be	 entirely	 appropriate	
given	the	patient’s	condition(s).	Inappropriate	prescribing	therefore	should	be	
defined	as	“the	use	of	medicines	whose	potential	harms	outweigh	their	benefits	




risk	 of	 adverse	 drug	 reactions	 outweighs	 any	 potential	 clinical	 benefits	
particularly	 when	 safer	 and	more	 effective	medicines	 are	 available.	 The	 risk	
associated	 with	 the	 prescribing	 of	 PIMs	 is	 the	 emergence	 of	 adverse	 drug	
reactions	in	patients.	This	has	the	potential	to	result	in	an	unintended	hospital	
admission,	 an	 A&E	 visit	 and	 increased	mortality	 and	morbidity	 (Bjerre	 et	 al.	
2015).	 A	 variety	 of	 screening	 tools	 have	 been	 developed	 to	 assess	 the	




a	categorical	 list	of	drugs	 that	are	considered	as	potentially	 inappropriate	 for	
individuals	(Kashyap	and	Iqbal	2014).				
Although	the	implicit	approach	is	perhaps	the	preferred	model	as	it	is	based	on	
assessing	 the	 patient,	 their	 conditions	 and	 their	 medicines,	 it	 is	 a	 time-
consuming	 approach	 and	 is	 dependent	 on	 the	 knowledge	 and	 skills	 of	 the	
clinician	 and	 their	 subsequent	 judgment	 according	 to	 each	 individual.	While	
explicit	 criteria	 lack	 the	 person-centered	 approach,	 they	 provide	 a	 set	 of	
consistent	 standards	 (drug	 or	 disease	 oriented)	 that	 are	 approved	 by	 a	




make	 judgments	on	 the	 current	best	 evidence.	 They	also	provide	 for	 a	desk-






















Derived	 from	 published	 reviews,	
expert	 opinions	 and	 consensus	
techniques	 without	 clinical	
judgement	 about	 the	 presenting	
patient.		
Identifies	 and	 groups	 medications	 that	 may	 be	
inappropriate	for	older	adults	into	three	categories:	
(i)	drugs	that	should	be	avoided	in	older	adults;	(ii)	
drugs	 that	 exceed	 the	 maximum	 recommended	
daily	 dose;	 (iii)	 drugs	 that	 should	 be	 avoided	 in	
combination	with	specific	co-morbidity.	
The	 criteria	 do	 not	 contain	 all	 causes	 of	 potentially	























those	 drugs	 which	 should	 be	 avoided	 in	 older	 adults	




Primarily	 based	 on	 Beer’s	 and	
McLeod	 criteria.	 Updated	 and	





along	 with	 their	 ATC	 code	 for	 ease	 of	 use	 and	
matches	data	on	an	international	level.	
The	 criteria	 is	 based	 on	 observations	 from	 one	 clinical	
setting	in	one	region	i.e.	long	term	care	settings	in	Quebec	
City.	 It	 is	 also	 more	 oriented	 towards	 assessment	 of	








always	 be	 avoided	 in	 elderly.	 It	
identifies	 rates	 of	 inappropriate	
prescribing	 in	 the	 elderly	 based	 on	
Beer’s	criteria.		
It	 is	 currently	 being	 used	 in	 the	 2006	Health	 Plan	
Employer	Data	and	Information	Set	(HEDIS)	in	2006	
to	assess	quality	of	care	for	older	Americans		
The	 criteria	 does	 not	 include	 all	 the	drugs	 listed	 in	 Beers	

















of	 Older	 People’s	 potentially	
inappropriate	 Prescriptions).	 It	
incorporates	 commonly	 encountered	
instances	 of	 potentially	 inappropriate	
prescribing	 in	 older	 people	 including	
drug-drug	and	drug-disease	interactions,	
drugs	which	adversely	affect	older	adults	
at	 risk	 of	 falls	 and	 duplicate	 drug	 class	
prescriptions.	
The	 criteria	 are	 easy	 to	 use	 as	 they	 are	 based	 on	
physiological	systems	similar	to	the	pattern	of	most	
drug	formularies.	Each	criterion	is	accompanied	by	a	







a	 screening	 tool	 to	 alert	 prescribers	 to	
the	right	treatment.	It	was	prepared	and	
validated	 for	 identifying	 prescribing	
omissions	in	older	adults.		
It	 is	 a	 valid,	 reliable	 and	 comprehensive	 screening	









These	 explicit	 criteria	 list	 high-risk	
medications	 with	 potential	 adverse	
reactions,	drug-disease	 interactions	and	
drug-drug	interactions.	According	to	this	
list	 drugs	 acting	 on	 central	 nervous	
system,	 musculoskeletal	 system	 and	
cardiovascular	 system	 were	 high-risk	
medications	in	elderly.	
This	 list	 has	 addressed	 different	 issue	 of	
inappropriate	 prescribing	 and	 most	 of	 identified	









An	 implicit	 criterion	 developed	 by	
Hanlon	 et	 al	 in	 1992	 and	 modified	 in	
1997.	 It	 is	 intended	 to	 be	 a	 reliable,	
standardized	 method	 of	 addressing	
multiple	 elements	 of	 prescribing,	
applicable	 to	 a	 variety	 of	 medications,	
clinical	conditions	and	settings.	
Excellent	 intra-rater	 and	 inter-rater	 reliability	
associated	with	 this	 tool	which	was	 tested	 in	both	
the	 inpatient	 and	 ambulatory	 settings.	 It	 has	
numerous	 components	 to	 check	 the	
appropriateness	of	a	medicine	and	can	be	applied	to	










a	variety	of	organisations	have	sought	 to	establish	national	 standards	 for	 the	
prescribing	of	a	range	of	medicines	called	National	Prescribing	Indicators.	These	





Group	 2017)	 and	 feature	 three	 distinct	 categories:	 (i)	 safety	 indicators;	 (ii)	
antimicrobial	stewardship	indicators	and	(iii)	efficiency	indicators.	Whilst	not	all	
the	 indicators	 are	 directly	 relevant	 to	 the	 care	 home	 setting,	 anticholinergic	
burden	is	a	key	indicator	in	this	setting.			
2.1.5.1.1 Anticholinergic	Burden	
Residents	 in	 care	 homes	 are	 widely	 prescribed	 drugs	 with	 anticholinergic	
properties	 (DAP)	 to	 treat	 a	 variety	 of	 disorders	 including	 gastrointestinal	
disturbances,	motion	 sickness,	 sleep	 disorders	 and	 Parkinson’	 disease.	 These	
drugs	exert	their	action	through	blockade	of	muscarinic	receptors.	However,	the	




related	 changes	 in	 pharmacokinetic	 and	 pharmacodynamics	 which	 may	
exacerbate	 their	 impact	 on	 this	 vulnerable	 population.	 Even	when	 individual	
medicines	 have	 a	 low	 level	 of	 anticholinergic	 activity,	 	 where	 they	 are	 used	



















School	 of	 Pharmacy	 and	 Pharmaceutical	 Sciences	 (SPPS)	 Research	 Ethics	
Committee	 (see	 Appendix	 1).	 	 This	 study	 involved	 secondary	 analysis	 of	
anonymised	 patient	 data	 therefore	 consent	 from	 individual	 resident	was	 not	
required.	
2.3.2 Recruitment	of	care	homes	
This	 project	 formed	 part	 of	 a	 wider	 study	 funded	 by	Welsh	 Government	 to	
explore	 the	 implementation	of	 an	 electronic	MAR	 system.	 The	project	was	 a	
collaboration	 between	 Cardiff	 University	 and	 a	 commercial	 partner,	 Invatech	
Health.	Recruitment	was	led	by	Invatech	Health	although	the	inclusion/exclusion	
criteria	and	the	recruitment	methodology	were	developed	in	partnership.	Ten	
care	 homes	 were	 recruited	 by	 purposive	 sampling	 from	 the	 Abertawe	 Bro	
Morgannwg	University	Health	 Board	 (ABMU)	 in	Wales.	 To	 be	 eligible	 for	 the	
study,	 the	nursing	or	residential	home	had	to	be	 located	 in	the	ABMU	health	















An	 introductory	 letter	was	 sent	out	 from	 the	ABMU	Health	Board	 to	 all	 care	
homes	to	invite	them	to	a	launch	event	to	find	out	more	about	the	project.	All	









to	 the	 pharmacy	 that	 supplied	 medication	 to	 the	 home	 and	 any	 further	
information	that	could	link	the	MAR	charts	to	any	single	person,	organisation	or	







(vii)	 type	 of	medication	 i.e.	whether	 regular	 or	 ‘when	 required’	medications.	















prevalence	 of	 potentially	 inappropriate	medicines	 use	 across	 the	medication	
profiles	of	260	residents	in	the	ten	care	homes	included	in	this	study.	The	2015	
Beers	criteria	classifies	53	medication	or	medication	classes	into	three	classes:	








did	 not	 have	 access	 to	 patient	 records	 that	 would	 have	 provided	 diagnostic	
criteria	for	prescribed	medications.		Only	one	modification	to	Beers	criteria	was	
made:	 Zopiclone	was	 included	 in	 the	 list	 of	 (non-benzodiazepines	 hypnotics)	










Beers	 criteria	 was	 applied	 to	 care	 home	 10	 (nursing	 home	 with	 specialised	
population	having	early	onset	dementia).	In	this	home,	some	residents	were	<	
65	 which	 is	 outside	 of	 the	 scope	 of	 Beers	 criteria.	 However,	 analysis	 of	 the	





















Highly	 anticholinergic;	 clearance	 reduced	 with	
advanced	age,	and	tolerance	develops	when	used	as	
hypnotic;	 risk	of	confusion,	dry	mouth,	constipation,	
and	 other	 anticholinergic	 effects	 or	 toxicity	 Use	 of	
diphenhydramine	 in	 situations	 such	 as	 acute	
treatment	 of	 severe	 allergic	 reaction	 may	 be	
appropriate	
Avoid	 Moderate	 Strong	 Antihistamine	
Antispasmodics	
Scopolamine	





acting	 (does	 not	 apply	 to	
the	 extended-	 release	
combination	with	aspirin)	
May	 cause	 orthostatic	 hypotension;	 more	 effective	
alternatives	 available;	 intravenous	 form	 acceptable	
for	use	in	cardiac	stress	testing	Safer,	
Avoid	 Moderate	 Strong	 Antiplatelet	
Anti-infective	
*Nitrofurantoin	
Potential	 for	 pulmonary	 toxicity,	 hepatoxicity,	 and	
peripheral	neuropathy,	especially	with	long-	term	use;	
safer	alternative	available	
Avoid	 in	 individuals	 with	
creatinine	 clearance	 <30	



















































Increased	 risk	 of	 cerebrovascular	 accident	 (stroke)	
and	greater	rate	of	cognitive	decline	and	mortality	in	
persons	 with	 dementia	 Avoid	 antipsychotics	 for	
behavioural	problems	of	dementia	or	delirium	unless	



























May	 be	 appropriate	 for	 seizure	 disorders,	 rapid	 eye	
movement	 sleep	 disorders,	 benzodiazepine	
withdrawal,	 ethanol	 withdrawal,	 severe	 generalized	
anxiety	disorder,	and	periprocedural	anesthesia	









Benzodiazepine-receptor	 agonists	 have	 adverse	
events	 similar	 to	 those	 of	 benzodiazepines	 in	 older	
adults	 (e.g.,	 delirium,	 falls,	 fractures);	 increased	
emergency	 department	 visits	 and	 hospitalizations;	
motor	vehicle	crashes;	minimal	improvement	in	sleep	
latency	and	duration	




hyperglycemia	 management	 regardless	 of	 care	
setting;	 refers	 to	 sole	 use	 of	 short-	 or	 rapid-acting	
insulins	to	manage	or	avoid	hyperglycemia	in	absence	
of	 basal	 or	 long-acting	 insulin;	 does	 not	 apply	 to	
titration	of	basal	insulin	or	use	of	additional	short-	or	





















Avoid	 scheduled	 use	 for	 >8	









due	 to	 failure	 of	 drug	







Increased	 risk	 of	 gastrointestinal	 bleeding	 or	 peptic	
ulcer	disease	in	high-risk	groups,	including	those	aged	
>75	 or	 taking	 oral	 or	 parenteral	 corticosteroids,	
anticoagulants,	or	antiplatelet	agents;	use	of	proton-
pump	 inhibitor	or	misoprostol	 reduces	but	does	not	
eliminate	 risk.	 Upper	 gastrointestinal	 ulcers,	 gross	
bleeding,	 or	 perforation	 caused	 by	 NSAIDs	 occur	 in	
approximately	1%	of	patients	treated	for	3–6	months	
and	 in	 ~2–4%	 of	 patients	 treated	 for	 1	 year;	 these	
trends	continue	with	longer	duration	of	use	
Avoid	 chronic	 use,	 unless	
other	 alternatives	 are	 not	
effective,	 and	 patient	 can	
take	gastro-	protective	agent	






























antidiuretic	 hormone	 secretion	 or	 hyponatremia;	
monitor	 sodium	 level	 closely	 when	 starting	 or	
changing	dosages	in	older	adults	





























































































made	 to	 identify	 drugs	 with	 anticholinergic	 properties	 (DAPs).	 Those	 with	
anticholinergic	 properties	 were	 scored	 (scale	 1	 –	 3)	 according	 to	 the	
Anticholinergic	 Effect	 on	 Cognition	 (AEC)	 criteria	 set	 out	 in	 the	 National	
Prescribing	 Indicators	 in	Wales	 2017-18	 (All	Wales	Medicines	 Strategy	Group	
2017).	A	total	AEC	score	was	then	calculated	for	each	resident.	
2.3.5 Statistical	analysis	
Univariate	 analysis	 (Pearson	 correlation)	 was	 performed	 to	 examine	 factors	
associated	with	PIMs	including;	(i)	average	age,	(ii)	prevalence	of	polypharmacy,	
(iii)	average	number	of	medications	prescribed	and	(iv)	number	of	residents	per	
care	 home.	 The	 analysis	 was	 conducted	 using	 Graph	 Pad	 Prism	 version	 7	




















patient	 was	 quite	 dramatic.	 In	 care	 home	 4	 there	 were	 examples	 where	




























19	 21	 25	 26	 53	 20	 17	 24	 14	 41	
Average	age	in	
years	±SD	(range)	
89±5(81-95)	 75±4(79-102)	 88±9(66-99)	 86±6(72-95)	 88±6(76-108)	 88±4(79-95)	 86±5(67-96)	 87±8(62-99)	 79±12(64-97)	 64±12(40-98)	
Number	of	meds	
prescribed	


































6(2-13)	 7(2-15)	 7(2-14)	 9(0-19)	 7(1-18)	 7(2-16)	 7(3-13)	 6(1-14)	 10.5(3-16)	 12(3-25)	
Mean	No	of	regular	
meds	per	resident	
5	 6	 6	 9	 6	 7	 7	 4	 8	 10	
Mean	No	of	PRN	
meds	per	resident	









commonly	 prescribed	 was	 the	 central	 nervous	 system	 which	 accounted	 for	
nearly	 32%	of	 the	medicines	 prescribed.	 This	was	 followed	by	 cardiovascular	
system	 at	 20%	 and	 gastro-intestinal	 system	 medications	 at	 15%.	 Combined,	
these	body	systems	accounted	for	more	than	65%	of	all	the	drugs	prescribed.	
Thereafter,	the	prescribing	for	other	body	systems	did	not	represent	more	than	




home	 level.	 The	 prescribing	 was	 found	 to	 be	 reasonably	 similar	 across	 the	
homes.	Drugs	 that	 act	 on	 the	 gastro-intestinal	 system,	 cardiovascular	 system	
and	nervous	system	were	the	top	three	therapeutic	areas	in	all	care	homes	(with	
the	 exception	 of	 care	 home	 10)	 and	 accounted	 for	 greater	 than	 59%	 of	
prescribed	medicines	in	all	homes.	Care	home	10,	which	specialises	in	the	care	













nervous	 system	 (~32%),	 cardiovascular	 system	 (~20%)	 and	 gastro-intestinal	 system	 (~15%)	
accounted	for	over	65%	of	all	the	drugs	prescribed.			
Total=2164 medicines prescribed
14.97%  Gastro-intestinal system
20.10%  Cardiovascular system
3.70%  Respiratory system
31.79%  Nervous system
4.57%  Infections
7.62%  Endocrine system
1.16%  Genito-urinary system
0.18%  Immune system and malignancy disease
9.43%  Blood and nutrition
1.94%  Musculoskeletal system










	 CH1	 CH2	 CH3	 CH4	 CH5	 CH6	 CH7	 CH8	 CH9	 CH10	 Mean	 S.D	
Gastro-intestinal	system	 15.04	 18.24	 17.61	 10.12	 13.58	 18.90	 14.52	 13.89	 16.33	 15.40	 15.36	 2.59	
Cardiovascular	system	 26.55	 25.00	 21.59	 21.05	 29.77	 17.07	 33.06	 28.47	 12.93	 6.82	 20.10	 8.11	
Respiratory	system	 4.42	 8.11	 1.14	 5.67	 2.35	 2.44	 3.23	 4.17	 6.80	 2.73	 3.70	 2.19	
Nervous	system	 19.47	 20.95	 29.55	 27.94	 21.67	 31.71	 16.94	 26.39	 40.82	 50.68	 31.79	 10.43	
Infections	 1.77	 9.46	 2.84	 9.72	 5.22	 3.66	 2.42	 2.78	 2.04	 3.51	 4.57	 2.93	
Endocrine	system	 12.39	 6.08	 8.52	 7.69	 9.40	 6.10	 8.06	 7.64	 4.08	 5.85	 7.62	 2.29	
Genito-urinary	system	 0.00	 1.35	 1.14	 2.83	 0.78	 1.22	 0.00	 2.08	 2.04	 0.58	 1.16	 0.92	
Immune	system	and	malignant	
disease	
0.88	 0.00	 0.00	 0.00	 0.26	 0.00	 0.81	 0.69	 0.00	 0.00	 0.18	 0.38	
Blood	and	nutrition	 11.50	 8.78	 7.95	 10.53	 10.70	 12.80	 7.26	 8.33	 7.48	 8.58	 9.43	 1.87	
Musculoskeletal	system	 0.00	 0.68	 2.84	 2.43	 1.57	 2.44	 4.84	 0.69	 2.04	 1.95	 1.94	 1.36	
Eye	 3.54	 1.35	 4.55	 1.21	 3.13	 2.44	 2.42	 0.00	 1.36	 0.00	 1.76	 1.49	
Skin	 4.42	 0.00	 2.27	 0.81	 1.31	 1.22	 6.45	 4.86	 4.08	 3.70	 2.68	 2.09	
Anaesthetic	 0.00	 0.00	 0.00	 0.00	 0.26	 0.00	 0.00	 0.00	 0.00	 0.19	 0.09	 0.10	
Total	number	of	medicines	





A	 sub-analysis	 of	 the	 medicines	 prescribed	 within	 the	 categories	 of	 (i)	
gastrointestinal	 system;	 (ii)	 endocrine	 system;	 (iii)	 nervous	 system;	 (iv)	
respiratory	system	and	(v)	cardiovascular	system	is	shown	in	Figure	2.3.		For	the	




diuretics	 were	 the	 most	 widely	 prescribed	 drugs	 at	 23%,	 17%	 and	 15%	
respectively.	 In	 terms	 of	 medicines	 acting	 on	 the	 gastro-intestinal	 system,	
laxatives	 (57%)	 and	 PPIs	 (32%)	 accounted	 for	 almost	 90%	 of	 medicines	
prescribed.	 Similarly,	 B2-agonist	 and	 antihistamines	 were	 the	 most	 widely	
prescribed	medicines	within	the	respiratory	area	at	40%	and	30%	respectively.	















1.23%  H2-receptor antagonist
32.41%  PPIs
Nervous system drugs




9.30%  Antipsychotic/1st generation





0.15%  Alcohol dependence
Endocrine system drugs
8.97%  Oral corticosteroids
5.13%  Insulin
23.08%  Oral diabetic drugs
23.08%  Disorders of bone metabolism
1.28%  Female sex hormone 
responsive therapy 





40.00%  Beta2 agonist
20.00%  Inhaled corticosteroids
2.50%  Mast cell stabiliser
1.25%  Mucolytic
Cardiovascular system drugs





8.74%  Calcium- blockers
16.78%  Diuretics
9.89%  ACI
2.30%  A II antagonist























1. Residential	 68%	 11%	
2. Nursing	 81%	 14%	
3. Nursing	 88%	 12%	
4. Nursing	 96%	 46%	
5. Nursing	 77%	 19%	
6. Nursing	 90%	 30%	
7. Nursing	 76%	 24%	
8. Residential	 75%	 17%	
9. Nursing	 93%	 71%	






care	homes.	A	 total	 of	 226	 residents	 (87%)	 received	at	 least	 one	PIM	and	of	
these,	 nearly	 half	 were	 prescribed	 three	 or	 more	 PIMs	 (43%),	 26%	 were	






















1	 19	 63%	 58%	 -----	 5%	
2	 21	 86%	 33%	 33%	 19%	
3	 25	 76%	 16%	 28%	 32%	
4	 26	 92%	 15%	 27%	 50%	
5	 53	 87%	 34%	 26%	 26%	
6	 20	 95%	 15%	 35%	 45%	
7	 17	 94%	 53%	 24%	 18%	
8	 24	 71%	 33%	 29%	 8%	
9	 14	 100%	 14%	 14%	 71%	
10	 41	 100%	 7	%	 10%	 83%	
	 Total	 87%	 31%	 26%	 43%	
	















1	 113	 																12%	 3%	 9%	
2	 148	 25%	 11%	 14%	
3	 176																													 28%	 17%	 11%	
4	 247	 28%	 15%	 13%	
5	 383																													 27%	 14%	 13%	
6	 164	 30%	 15%	 15%	
7	 124																													 22%	 12%	 10%	
8	 144	 21%	 8%	 13%	
9	 147																												 37%	 26%	 11%	
10	 513	 34%	 27	%	 7%	





be	avoided	was	 lower	 in	 the	 residential	homes	 than	 the	nursing	homes	 (care	
home	 1	 at	 3%	 to	 be	 avoided	 and	 care	 home	 8	 at	 8%	 to	 be	 avoided).	 The	
prevalence	of	PIMs	was	particularly	high	in	homes	9	and	10	where	PIMs	to	be	
avoided	accounted	for	more	than	25%	of	all	medicines	prescribed	(26%	and	27%	
respectively);	 in	 total	 PIMs	 accounted	 for	more	 than	 a	 third	 of	 all	medicines	
prescribed	in	care	homes	9	and	10	(37%	and	34%	respectively).		
A	breakdown	of	the	residents	receiving	either	PIMs	to	be	avoided	or	to	be	used	
with	 caution	 in	 each	 care	 home	 is	 provided	 in	 Table	 2.14.	 	 There	 was	 no	
discernible	pattern	in	the	data,	in	five	of	the	care	homes	patients	receiving	one	



















Care	Home	 Avoid	 Caution	 Avoid	 Caution	 Avoid	 Caution	 Avoid	 Caution	
1	 16%										47%	 11%		 47%	 5%											 ----	 ----	 ----	
2	 43%										71%	 19%												52%	 19%												19%	 5%	 ----	
3	 56%										56%	 20%												40%	 16%												16%	 20%												----	
4	 81%										73%	 38%												42%	 23%												19%	 19%											12%	
5	 68%										58%	 38%												38%	 28%												17%	 2%														4%	
6	 75%										75%	 35%												45%	 25%												20%	 15%											10%	
7	 59%										53%	 42%												41%	 12%													6%	 6%														6%	
8	 42%										50%	 42%												33%	 ----															13%	 ----														4%	
9	 93%										71%	 21%												36%	 21%													29%	 50%												7%	
10	 95%										56%	 10	%											39%	 17%													12%	 68%												5%	
Total	 60%										60%	 28%											41%	 18%	 	15%	 20%	 5%	
N.B.	some	residents	may	receive	PIM(s)	to	be	avoided	and	used	with	caution.	





with	 40%	 of	 all	 residents	 receiving	 a	 PPI	 followed	 by	 antipsychotics	 (32%),	
































prescribing	of	 at	 least	 one	PIM	 to	 a	 resident	was	 associated	with	 either	 age,	
number	of	residents	in	a	care	home,	mean	number	of	medicines	prescribed	per	
resident	 or	 the	 extent	 of	 polypharmacy.	 The	 analysis	 revealed	 a	 positive	
correlation	 between	 the	 prescribing	 of	 a	 PIM	 and	 the	 average	 number	 of	








Table	 2.16	 Pearson	 correlation	 between	 prevalence	 of	 PIMs	 and	 a	 range	 of	 parameters.	





Extent	of	polypharmacy	 0.7218	 (0.16-0.92)	 0.0184*	
Average	age	 -0.410	 (-0.82-0.29)	 0.2393	
Mean	number	of	meds	 0.8038	 (0.29-0.94)	 0.0051**	











an	 AEC	 score	 of	 two	 and	 66	 (25%)	 an	 AEC	 score	 of	 one.	 	 There	 was	 quite	
considerable	variability	 in	 the	prevalence	by	care	home.	For	example,	 in	care	
home	1,	just	2	residents	of	19	(~1%)	received	a	DAP	whilst	in	care	home	10	that	
rose	to	34	residents	of	41	(84%)	receiving	a	DAP.	Of	note	both	care	homes	9	and	
10	 had	 a	 significant	 percentage	 of	 residents	 (36%	 and	 54%	 respectively)	
attracting	 an	 AEC	 score	 of	 three	 or	more.	 	 As	 can	 be	 seen	 in	 Figure	 2.4,	 14	
residents	 (5.4%)	 accumulated	 AEC	 scores	 that	 place	 them	 at	 risk	 of	 severe	
cognitive	impairment	whilst	31	residents	(11.9%)	accumulated	scores	that	are	
likely	 to	be	 clinically	 relevant	 	 (Pfistermeister	 et	 al.	 2017).	Although	different	

















1	 19	 1	(5%)	 ----	 1	(5%)	
2	 24	 7	(29%)	 2	(8%)	 -----	
3	 25	 7	(28%)	 1	(4%)	 2	(8%)	
4	 26	 14	(54%)	 2	(8%)	 3	(12%)	
5	 53	 11	(21)	 4	(8%)	 5	(9%)	
6	 20	 7	(35%)	 4	(20%)	 3	(15%)	
7	 17	 2	(12%)	 ----	 2	(12%)	
8	 24	 6	(25%)	 4	(17%)	 2	(8%)	
9	 14	 3	(21%)	 3	(21%)	 5	(36%)	
10	 41	 8	(20%)	 4	(10%)	 22	(54%)	







































to	 be	 exposed	 to	 inappropriate	 prescribing	 compared	 to	 patients	 in	 other	
settings	 (Loganathan	 et	 al.	 2011;	 Shah	 et	 al.	 2012).	 The	 incidence	 of	







In	 this	 current	 study,	 the	medications	 prescribed	 to	 260	 residents	 in	 10	 care	
homes	in	the	Abertawe	Bro	Morgannwg	University	Health	Board	were	examined	
through	a	retrospective	analysis	of	paper-based	MAR	charts	that	covered	a	28-
day	medicines	 cycle	 (September	 to	October	 2014);	 this	 provided	 a	 surrogate	
prescribing	data	set	as	currently	 there	 is	no	national	data	set	 that	specifically	
details	prescribing	 in	 care	homes.	A	number	of	parameters	were	explored	 to	
assess	the	landscape	of	prescribing	including	(i)	the	prevalence	of	polypharmacy	
(³	 	 5	 medicines	 prescribed)	 and	 excessive	 polypharmacy	 (³	 10	 medicines	
prescribed);	(ii)	the	prevalence	of	potentially	inappropriate	medicines	as	defined	
by	Beers	criteria	 for	Potentially	 Inappropriate	Medication	Use	 in	Older	Adults	
and	(iii)	the	anticholinergic	burden	placed	on	residents	due	to	their	medicines.		
All	medicines	were	 included	 in	 the	 analysis	with	 the	 exception	 of	 borderline	
substances	and	appliances.		
As	has	been	demonstrated	in	the	literature,	the	care	home	residents	explored	in	









colleagues	 explored	 the	 number	 of	 medicines	 an	 individual	 was	 prescribed	
immediately	prior	to	entering	a	care	home	and	then	six	weeks	later.		The	authors	
found	 a	 small	 but	 significant	 increase	 in	 the	 mean	 number	 of	 medications	
prescribed	to	residents	and	the	 increase	was	most	pronounced	for	medicines	
that	act	on	the	central	nervous	(Koopmans	et	al.	2003).		





consistent.	 For	 example	 in	 the	 seminal	 CHUMS	 study,	 investigators	 reviewed	
MAR	charts	for	256	resident	across	55	UK	care	homes	(residential,	nursing	and	
mixed)	and	found	that	residents	received	an	average	of	8	medications	(Alldred	
et	 al.	 2009).	 Similarly,	 	 Gordon	 and	 colleagues	 	 reported	 an	 average	 of	 8	
medicines	per	resident	in	a	cohort	study	conducted	in	11	care	homes	in	the	UK	
(Gordon	et	al.	2014).	
Similar	 findings	 have	 been	 demonstrated	 internationally.	 For	 example,	 Beers	
and	 colleagues	 investigated	 patterns	 of	 medication	 use	 in	 12	 care	 homes	
housing	 850	 residents	 in	 the	 US	 (Beers	 et	 al.	 1988).	 They	 determined	 that	











Despite	 some	variability	 in	 the	 average	number	of	medications	prescribed	 to	
residents	 across	 these	 studies,	 all	 studies	 conclude	 that	 there	 is	 a	 high	
prevalence	 of	 polypharmacy	 in	 the	 older	 adult	 care	 home	 population.	
Polypharmacy	 has	 been	 described	 in	 a	 number	 of	 ways	 (see	 section	 2.1.4)	









variable	 in	 this	 regard.	 For	 example	 in	 a	 European	 study	 	 (Czech	 Republic,	
England,	 Finland,	 France,	Germany,	 Italy,	 and	The	Netherlands)	 in	 57	nursing	











Similar	 findings	were	observed	 in	 the	US	 through	 the	National	Nursing	Home	








conclusively	 determine	 the	 reasons	 for	 this	 variability,	 however	 a	 number	 of	




some	homes.	 Indeed,	 in	 this	 current	 study,	 residents	of	 care	home	10	which	
specialized	in	the	care	of	individuals	with	dementia	were	found	to	have	a	higher	
prevalence	 of	 polypharmacy	 (95%)	 and	 excessive	 polypharmacy	 (66%)	 in	
comparison	to	other	homes.		Of	the	ten	care	homes	included	in	this	study,	eight	






consequence	 of	 drug	 related	 problems	 related	 to	 drug-drug	 interactions,	









of	 polypharmacy	 were	 higher	 than	 in	 other	 settings.	 	 Also,	 Delcher	 and	
colleagues	found	a	direct	relationship	between	the	number	of	medications	used	





drug-drug	 interactions	 was	 increased	 from	 50%	 in	 patients	 taking	 5-9	










period.	 	Using	 a	multiple	 logistic	 regression	 analysis,	 the	 absolute	number	of	
drugs	prescribed	was	significantly	associated	with	the	incidence	of	falls	and	was	
independent	of	age,	sex	and	extent	of	comorbidity	(Kojima	et	al.	2012).		
One	 of	 the	 factors	 partly	 responsible	 for	 polypharmacy	 is	 thought	 to	 be	
‘prescribing	cascades’.	A	prescribing	cascade	is	defined	as	a	process	where	the	
adverse	effects	of	one	drug	are	misdiagnosed	as	a	new	symptom	that	results	in	


















al.	 2001).	While	 other	 studies	 have	 found	 that	 being	 85	 and	 over	 is	 strongly	










Beyond	 the	 clinical	 consequences	 to	 the	 resident,	 polypharmacy	 has	 been	
associated	with	 increasing	health	care	expenditure.	For	example,	a	study	was	





4.8%	 and	 for	 patients	 with	 polypharmacy	 or	 excessive	 polypharmacy	 PDE	
increased	by	6.2%	and	7.3%	respectively.	Of	note	in	a	simulation	that	sought	to	
neutralise	 increases	 in	polypharmacy,	no	 increase	 in	 total	PDE	was	measured	
(Hovstadius	and	Petersson	2013).	Similarly,	the	increased	incidence	of	adverse	






data,	 polypharmacy	 was	 a	 major	 predictor	 of	 potentially	 inappropriate	
prescribing,	 increased	 outpatient	 visits	 and	 risk	 for	 hospital	 admission	 that	





estimated	 cost	 of	 $2184	 per	 resident.	 	 The	 authors	 found	 that	 older	 adults	
receiving	multiple	medications	 in	 nursing	 home	were	 associated	with	 higher	
expenditure	 (Kamboj	 et	 al.	 1999).	 These	 costs	 appear	 to	 be	 rising	 with	 for	
example,		Trygstad	and	colleagues	reporting	the	cost	of	medicines	had	reached	
nearly	 $6000	per	 resident	 per	 year	 in	 253	US	 nursing	 homes	 (Trygstad	 et	 al.	
2005).		
There	have	been	a	number	of	studies	which	have	sought	to	examine	a	range	of	
interventions,	 primarily	 pharmacist	 lead,	 to	 reduce	 the	 prevalence	 of	




resident,	 although	 no	 change	 in	 drug	 costs	 was	 observed	 (Zermansky	 et	 al.	
2006).	 	 Furniss	 and	 colleagues	 reported	 a	 decrease	 in	 the	 mean	 number	 of	
prescribed	medication	 from	5.4	 to	4.2	during	a	pharmacist	 intervention	 in	14	
nursing	homes	in	the	UK	(Furniss	et	al.	2000).	The	clinical	consequences	of	such	
interventions	 remains	 equivocal	 however	 with	 some	 studies	 reporting	 that	
medication	 reviews	 do	 not	 improve	 mortality	 rates	 or	 functional	 capacity	
(Zermansky	and	Silcock	2009)	or	reduce	hospital	admissions	(Wallerstedt	et	al.	
2014).		
In	 this	 current	 study,	 there	 was	 an	 exploration	 of	 the	 general	 prescribing	














the	 trends	 in	 analgesic	prescribing	 to	 care	home	 residents	 in	Norway	 for	 the	






















the	 prescribing	 of	 psychotropic	 drug	 was	 significantly	 higher	 in	 care	 home	






Wastila	 et	 al.	 2014).	 	Given	 that	 their	 efficacy	 in	older	 adults	 is	 questionable	
(Wilfling	 et	 al.	 2015),	 there	 has	 been	 much	 discussion	 in	 the	 popular	 press	
surrounding	 the	 use	 of	 antipsychotics	 in	 older	 adults	 in	 care	 homes	 and	








cognitive	 impairments	 (Foy	 et	 al.	 1995;	Nazareth,	 Burkhardt	 2008)	 especially	
when	 such	medications	 are	used	 for	 extended	periods.	Ultimately,	 the	wide-




Another	 area	 of	 prescribing	 in	 older	 adults	 that	 has	 seen	 intense	 scrutiny	 in	
recent	years	 is	 the	use	of	drugs	with	anticholinergic	properties	 (DAPs)	due	to	





the	 Anticholinergic	 Effect	 on	 Cognition	 scale,	 a	 score	 was	 calculated	 for	 any	





highest	 incidence	of	anticholinergic	burden	was	 seen	 in	 care	home	10	where	
more	 than	 half	 the	 residents	 had	 an	 AEC	 Sore	 of	 three	 or	 more.	 This	 is	 a	
concerning	finding	as	dementia	patients	will	have	pre-existing	cognitive	decline	
which	is	likely	to	be	exacerbated	by	the	anticholinergic	burden.		
With	 regards	 to	 medicines	 that	 act	 in	 the	 gastro-intestinal	 system,	 the	





this	 cohort	 particularly	 related	 to	 age,	 lack	 of	mobility,	 poor	 diet	 or	 the	 side	
effects	 of	 a	 number	 of	 medications	 commonly	 used	 in	 this	 population		
(Suominen	et	al.	2005;	Ehrenberg	and	Ehnfors	1999).		However,	this	may	lead	to	
chronic	use	of	laxatives	in	some	residents	which	may	cause	further	drug	related	





of	medicines	 use	 in	 care	 home	 residents,	 it	 is	 less	 useful	 in	 determining	 the	
appropriateness	 of	 prescribed	 medicines.	 It	 is	 more	 useful	 to	 assess	 the	













PIMs	were	 sub-categorised	 into	 those	 that	 should	be	avoided	and	 those	 that	
should	be	used	with	caution.	Some	60%	of	residents	received	at	least	one	PIM	
that	should	be	avoided	and	20%	received	three	or	more	PIMs	that	should	be	
avoided.	Similarly,	60%	of	 residents	 received	at	 least	one	PIM	that	 should	be	
used	with	caution	but	only	5%	received	three	or	more	PIMs	that	should	be	used	
with	caution.	Some	residents	received	a	combination	of	PIMs	to	be	avoided	and	
used	 with	 caution	 (data	 not	 shown).	 Irrespective	 of	 this,	 the	 prevalence	 of	




residents.	 The	 reported	 prevalence	 shows	 a	 high	 degree	 of	 variability	 with	
studies	reporting	a	prevalence	of	at	 least	one	PIM	anywhere	between	20%	to	












heterogeneity	 in	 the	 literature	 might	 be	 influenced	 by	 the	 unavailability	 of	
certain	medications	in	different	countries	or	due	to	differences	in	study	design	
and	 duration,	 it	 is	 clear	 that	 there	 is	 a	 substantial	 level	 of	 potentially	
inappropriate	 prescribing	 to	 care	 home	 residents	 both	 nationally	 and	
internationally.	
In	agreement	with	findings	related	to	polypharmacy,	the	prevalence	of	PIMs	was	
lower	 in	 the	two	residential	care	homes	 included	 in	 this	study.	 	Although	the	
numbers	are	small,	this	finding	might	suggest	that	residents	in	residential	homes	
are	 less	 likely	 to	 have	 complex	 clinical	 conditions	 requiring	 prescribing	
interventions	 compared	 to	 those	 in	 nursing	 home.	 Care	 home	 1	 had	 a	
particularly	interesting	pattern	of	PIMs	where	the	prevalence	of	medicines	to	be	




It	 should	 be	 noted	 that	 the	 study	 design	 utilised	 here	 did	 not	 allow	 for	 a	
determination	of	the	reasons	why	residents	were	prescribed	PIMs	i.e.	whether	
it	is	related	to	poor	prescribing	habits,	non-evidence-based	indications,	complex	
health	 conditions	 associated	 with	 the	 residents,	 or	 the	 prescribing	 cascade	
phenomenon.	Therefore,	further	studies	should	seek	to	address	this	gap	in	the	
knowledge	 base	 using	 a	 resident’	medical	 records	 to	make	 a	 comprehensive	
judgment	with	regards	to	the	appropriateness	of	medications	used	according	to	
each	clinical	condition.	
In	 this	 study,	 a	 moderate	 negative	 correlation	 was	 identified	 between	 the	
prevalence	of	PIMs	and	advancing	age	which	is	in	agreement	with	other	studies	
(O’Sullivan	et	al.	2013;	Vieira	De	Lima	et	al.	2013).		It	is	unclear	why	this	is	the	














are	 more	 likely	 to	 be	 prescribed	 PIMs	 (Pinto	 et	 al.	 2013;	 Rigler	 et	 al.	 2004;	
Bierman	et	al.	2007).	Other	studies	have	found	that	poor	health	status	(Fu	et	al.	
2004)	and	multiple	 co-morbidities	are	 risk	 factors	 for	 the	prescribing	of	PIMs	
(Chin	et	al.	1999;	Klarin	et	al.	2005;	Vieira	de	Lima	et	al.	2013;	Elseviers	et	al.	








in	 a	 case	 control	 study	 in	 the	 USA	 with	 17,198	 patients	 aged	 65	 and	 over	













al.	 2007).	 As	Gallagher	 and	O’Mahony	 noted,	 nearly	 half	 of	 715	 older	 adults	
receiving	Beers	criteria	PIMs	were	subjected	to	acute	hospital	admission	due	to	
their	related	adverse	drug	events	in	the	UK	(Gallagher	and	O’Mahony	2008).	This	
was	 confirmed	 by	 a	 prospective	 study	 conducted	 in	 six	 European	 teaching	





care	 patients	 aged	 65	 and	 over,	 a	 significant	 association	 was	 demonstrated	
between	high	prevalence	of	PIMs	use	and	total	cost	paid	(p	<	0.0001)	(Fick	et	al.	
2001).	 Similarly,	 a	 study	 by	 Donna	 and	 colleagues	 in	 a	 community	 dwelling	
population	with	17,971	individual	aged	65	and	over	in	the	USA,	reported	a	two-















psychotropic	 drugs	 versus	 behavioral	 management	 techniques	 (Fossey	 et	 al.	
2006;	B.	F.	Hagen	et	al.	2005;	Meador	et	al.	1997).	These	studies	have	found	a	
decrease	 in	 the	number	of	 residents	using	 such	medications	or	 reductions	 in	
their	 dosages	 with	 training.	 Other	 studies	 have	 emphasised	 the	 role	 of	 the	
pharmacist	or	the	multidisciplinary	team	in	reducing	inappropriate	prescribing	
through	medication	reviews	or	the	use	of	screening	tools.	These	interventional	
approaches	 generally	 focus	 on	 deprescribing.	 Deprescribing	 is	 defined	 as	 ‘a	








adults	 in	 ten	 care	 homes	 in	 the	 South	 Wales	 region.	 The	 prevalence	 of	
polypharmacy	(5+	medicines),	excessive	polypharmacy	(10+	medicines)	and	the	
use	of	potentially	inappropriate	medicines	was	significant	but	in	line	with	studies	
in	 the	 literature.	 A	 significant	 number	 of	 residents	 were	 also	 exposed	 to	 a	
significant	anticholinergic	burden.	Together,	this	is	likely	to	place	some	residents	
at	risk	of	cognitive	impairment,	geriatric	syndromes	and	increased	morbidity	and	
mortality.	 In	 an	 already	 vulnerable	 population,	 careful	 consideration	 of	










Abad,	 V.C.	 and	 Guilleminault,	 C.	 2018.	 Insomnia	 in	 Elderly	 Patients:	
Recommendations	for	Pharmacological	Management.	Drugs	&	Aging	35(9),	pp.	
791–817.		




older	 persons.	 American	 Geriatrics	 Society,	 British	 Geriatrics	 Society,	 and	
American	Academy	of	Orthopaedic	Surgeons	Panel	on	Falls	Prevention.	Journal	
of	the	American	Geriatrics	Society	49(5),	pp.	664–72.		




errors	 in	 nursing	 &	 residential	 care	 homes-prevalence,	 consequences	 and	





















Ballentine,	 N.H.	 2008.	 Polypharmacy	 in	 the	 Elderly.	 Critical	 Care	 Nursing	
Quarterly	31(1),	pp.	40–45.	
Barnett,	 K.	 et	 al.	 2011.	 Prevalence	 and	 outcomes	 of	 use	 of	 potentially	
inappropriate	medicines	in	older	people:	Cohort	study	stratified	by	residence	in	
nursing	home	or	in	the	community.	BMJ	Quality	and	Safety	20(3),	pp.	275–281.	





Beers,	 M.H.	 et	 al.	 1991.	 Explicit	 Criteria	 for	 Determining	 Inappropriate	
Medication	Use	 in	Nursing	Home	Residents	Substanti	 a	 l.	Archives	of	 internal	
medicine	151,	pp.	1825–32.	
Beloosesky,	 Y.	 et	 al.	 2013.	 Rates,	 variability,	 and	 associated	 factors	 of	





Bierman,	A.S.	 et	 al.	 2007.	 Sex	differences	 in	 inappropriate	prescribing	among	



























older	 people:	 a	 national	 population	 study.	 British	 journal	 of	 clinical	
pharmacology	69(5),	pp.	543–52.	
Campbell,	 N.	 et	 al.	 2009.	 The	 cognitive	 impact	 of	 anticholinergics:	 a	 clinical	
review.	Clinical	interventions	in	aging,	4,	p.225.		













Chin,	 M.H.	 et	 al.	 1999.	 Appropriateness	 of	 Medication	 Selection	 for	 Older	
Persons	 in	 an	Urban	Academic	Emergency	Department.	Academic	Emergency	
Medicine	6(12),	pp.	1232–1241.		






Conn,	 D.K.	 and	 Seitz,	 D.P.	 2010.	 Advances	 in	 the	 treatment	 of	 psychiatric	
disorders	in	long-term	care	homes.	Current	opinion	in	psychiatry	23(6),	pp.	516–
21.		
Cook	 K.,	 	 and	 S.L.M.	 2013.	Urinary	 Incontinence	 in	 the	 Older	 Adult	 [Online]	
Available	 at:	 https://www.accp.com/docs/bookstore/psap/p13b2_m1ch.pdf	
[Accessed:	30	October	2018].	

































M.	 and	 Galloway,	 J.,	 2015,	 October.	 Polypharmacy	 is	 a	 predictor	 of	
hospitalisation	 in	 patients	 with	 rheumatoid	 arthritis.	 In	 ARTHRITIS	 &	
RHEUMATOLOGY	 (Vol.	 67).	 111	 RIVER	 ST,	 HOBOKEN	 07030-5774,	 NJ	 USA:	
WILEY-BLACKWELL.	
Fiss,	T.	et	al.	2011.	Frequency	of	inappropriate	drugs	in	primary	care:	Analysis	of	
a	 sample	 of	 immobile	 patients	 who	 received	 periodic	 home	 visits.	 Age	 and	
Ageing	40(1),	pp.	66–73.	
Fong,	 T.G.	 et	 al.	 2009.	 Delirium	 in	 elderly	 adults:	 diagnosis,	 prevention	 and	
treatment.	Nature	reviews.	Neurology	5(4),	pp.	210–20.		
Fossey,	J.	et	al.	2006.	Effect	of	enhanced	psychosocial	care	on	antipsychotic	use	
in	 nursing	 home	 residents	 with	 severe	 dementia:	 Cluster	 randomised	 trial.	
British	Medical	Journal	332(7544),	pp.	756–758.	
Fox,	 C.	 et	 al.	 2014.	 Effect	 of	medications	 with	 anti-cholinergic	 properties	 on	
cognitive	 function,	 delirium,	 physical	 function	 and	 mortality:	 a	 systematic	
review.	Age	and	ageing	43(5),	pp.	604–15.		
Foy,	A.	et	al.	1995.	Benzodiazepine	use	as	a	cause	of	cognitive	 impairment	 in	
elderly	 hospital	 inpatients.	 The	 journals	 of	 gerontology.	 Series	 A,	 Biological	
sciences	and	medical	sciences	50(2),	pp.	M99-106.		
Franchi,	 C.	 et	 al.	 2013.	Geographical	 differences	 in	 the	prevalence	of	 chronic	




French,	 D.D.	 et	 al.	 2007.	 A	 multivariate	 fall	 risk	 assessment	 model	 for	 VHA	


























problem,	 working	 to	 a	 solution:	 a	 systematic	 review	 of	 the	 literature.	 BMC	
medicine	7,	p.	50.	
Garfinkel,	 D.	 et	 al.	 2010.	 Feasibility	 study	 of	 a	 systematic	 approach	 for	
discontinuation	 of	 multiple	 medications	 in	 older	 adults.	 Archives	 of	 Internal	
Medicine	170(18),	pp.	1648–1654.	
Gillette,	 C.	 et	 al.	 2015.	 A	 new	 lexicon	 for	 polypharmacy :	 Implications	 for	
research	 ,	 practice	 ,	 and	 education.	 Research	 in	 Social	 and	 Administrative	
Pharmacy	11(3),	pp.	468–471.		
Gordon,	 	 a.	 L.	et	al.	2014.	Health	 status	of	UK	care	home	 residents:	a	 cohort	
study.	Age	and	Ageing	43(1),	pp.	97–103.		














































Hughes,	 P.J.	 et	 al.	 2016.	 Common	 issues	 in	 the	medication	 use	 processes	 in	
nursing	 homes:	 a	 review	 of	 medication	 use	 quality	 improvement	 strategies.	
Journal	of	Nursing	Education	and	Practice	6(7),	pp.	81–90.		
Huybrechts,	K.F.	et	al.	2012.	Comparative	safety	of	antipsychotic	medications	in	









Inouye,	 S.K.	 et	 al.	 2007.	 Geriatric	 syndromes:	 clinical,	 research,	 and	 policy	
implications	 of	 a	 core	 geriatric	 concept.	 Journal	 of	 the	 American	 Geriatrics	
Society	55(5),	pp.	780–91.		
International	 Longevity	 Centre-UK	 2013.	 The	 Burden	 of	 Constipation	 in	 our	
Ageing	 Population	 [Online]	 Available	 at:	
http://www.burdenofconstipation.com/wp-


























Scheme	 (PBS)	 on	 inappropriate	 prescribing	 in	 Australian	 nursing	 homes.	
Pharmacy	world	&	science :	PWS	29(1),	pp.	39–42.		
Klarin,	 I.	 et	 al.	 2005.	 The	 association	 of	 inappropriate	 drug	 use	 with	
hospitalisation	and	mortality:	a	population-based	study	of	the	very	old.	Drugs	
Aging.	22(1),	pp.	69–82.	




Koria,	 L.G.	 et	 al.	 2018.	 Impact	 of	 medication	 reviews	 on	 inappropriate	
prescribing	in	aged	care.	Current	Medical	Research	and	Opinion	34(5),	pp.	833–
838.		




























Mamun,	 K.	 et	 al.	 2004.	 Polypharmacy	 and	 Inappropriate	 Medication	 Use	 in	
Singapore	Nursing	Homes.	Annals	of	the	Academy	of	Medicine	Singapore	33(1),	
pp.	49–52.	
Mangoni,	 A.A.	 and	 Jackson,	 S.H.D.	 2003.	 Age-related	 changes	 in	
pharmacokinetics	 and	 pharmacodynamics:	 basic	 principles	 and	 practical	
applications.	British	Journal	of	Clinical	Pharmacology	57(1),	pp.	6–14.	

















medicine	 use	 in	 older	 New	 Zealanders:	 a	 population-level	 study	 using	 the	
updated	2012	Beers	criteria.	Journal	of	evaluation	in	clinical	practice	21(4),	pp.	
633–41.		
National	 Committee	 on	 Quality	 Assurance	 2018.	 HEDIS	 and	 Performance	
Measurement	[Online]	Available	at:	https://www.ncqa.org/hedis/	[Accessed:	30	
October	2018].	




Naugler,	 C.T.	 et	 al.	 2000.	 Development	 and	 validation	 of	 an	 improving	
prescribing	in	the	elderly	tool.	The	Canadian	journal	of	clinical	pharmacology	=	
Journal	canadien	de	pharmacologie	clinique	7(2),	pp.	103–7.	









































Pinto,	 M.C.X.	 et	 al.	 2013.	 Potentially	 inappropriate	 medication	 use	 among	
institutionalized	elderly	 individuals	 in	 southeastern	brazil.	Brazilian	 Journal	 of	
Pharmaceutical	Sciences	49(4),	pp.	709–717.	
Rancourt,	 C.	 et	 al.	 2004.	 Potentially	 inappropriate	 prescriptions	 for	 older	
patients	in	long-term	care.	BMC	Geriatrics	4,	pp.	1–9.	
Ray,	W.A.	 et	 al.	 2000.	 Benzodiazepines	 and	 the	 risk	 of	 falls	 in	 nursing	 home	
residents.	Journal	of	the	American	Geriatrics	Society	48(6),	pp.	682–5.		
Rigler,	S.K.	et	al.	2004.	Comparison	of	the	association	between	disease	burden	


























Salahudeen,	M.S.	 et	 al.	 	 2015.	 Comparison	 of	 anticholinergic	 risk	 scales	 and	





Sandvik,	 R.	 et	 al.	 2016.	 Analgesic	 prescribing	 patterns	 in	 Norwegian	 nursing	
homes	from	2000	to	2011:	trend	analyses	of	four	data	samples.	Age	and	Ageing	
45(1),	pp.	54–60.		























in	 nursing	 home	 residents.	 Research	 in	 Social	 and	 Administrative	 Pharmacy	
10(3),	pp.	494–507.		
Smith,	 P.	 et	 al.	 2015.	 Focus	 on:	 Hospital	 admissions	 from	 care	 homes	 About	







Stafford,	 A.C.	 et	 al.	 2011.	 Inappropriate	 prescribing	 in	 older	 residents	 of	
Australian	care	homes.	Journal	of	Clinical	Pharmacy	and	Therapeutics	36(1),	pp.	
33–44.	
Stajkovic,	 S.	 et	 al.	 2011.	 Unintentional	 weight	 loss	 in	 older	 adults.	 CMAJ :	
Canadian	 Medical	 Association	 journal	 =	 journal	 de	 l’Association	 medicale	
canadienne	183(4),	pp.	443–9.		







Stevenson,	 D.G.	 et	 al.	 2010.	 Antipsychotic	 and	 benzodiazepine	 use	 among	
nursing	home	residents:	findings	from	the	2004	National	Nursing	Home	Survey.	

























Verrue,	 C.	 et	 al.	 2012.	 A	 pharmacist-conducted	medication	 review	 in	 nursing	
home	 residents:	 impact	 on	 the	 appropriateness	 of	 prescribing.	 Acta	 clinica	
Belgica	67(6),	pp.	423–9.	
Vetrano,	D.L.	et	al.	2014.	Predictors	of	length	of	hospital	stay	among	older	adults	












reduce	 mortality	 and	 hospitalization:	 systematic	 review	 and	 meta-analysis.	
British	journal	of	clinical	pharmacology	78(3),	pp.	488–97.	
Wang,	 P.S.	 et	 al.	 2001.	 Hazardous	 benzodiazepine	 regimens	 in	 the	 elderly:	
effects	of	half-life,	dosage,	and	duration	on	risk	of	hip	fracture.	The	American	
journal	of	psychiatry	158(6),	pp.	892–8.	
Wilfling,	 D.	 et	 al.	 2015.	 Non-pharmacological	 interventions	 for	 sleep	








Woodward,	M.C.,	 2003.	 Deprescribing:	 achieving	 better	 health	 outcomes	 for	
older	people	through	reducing	medications.	Journal	of	Pharmacy	Practice	and	
Research,	33(4),	pp.323-328.	






































When	 medicines	 are	 administered	 to	 residents	 in	 care	 homes,	 the	
administration	must	be	documented	on	Medicines	Administration	Record	(MAR)	
charts.	 MAR	 charts	 represent	 the	 core	 documentary	 record	 of	 medicines	
administration	 to	 residents.	 Each	 resident	 should	have	a	 separate	MAR	chart	
that		provides	details	about	the	resident	including	their	name,	date	of	birth	and	
allergy	 status,	 contains	 a	 list	 of	 all	 the	medicines	 to	 be	 administered	 to	 the	
resident	 with	 associated	 dosage	 instructions,	 any	 special	 instructions	 or	




broadly	 similar	 allowing	 for	 effective	 administration	 to	 the	 resident	 and	
subsequent	recording	of	such	an	administration.	In	general,	the	majority	of	care	






















existing	medication	may	change	 for	example	due	 to	changes	 in	 the	dose.	For	
interim	medications,	a	separate	MAR	chart	is	provided.	For	changes	to	existing	
medicines,	 a	 responsible	 staff	 member	 will	 hand	 amend	 the	 existing	 MAR	
chart(s)	 to	 reflect	 the	 changes	 in	 a	 clear	 and	 legible	 way;	 the	 prescriber	
instigating	these	changes	should	be	documented	and	all	amendments	should	be	
signed	and	witnessed.		
The	 act	 of	 recording	 medicines	 administrations	 is	 an	 important	 regulatory	
requirement.	 For	 example,	 under	 the	 Care	Homes	 (Wales)	 Regulations	 2002,	
each	 care	 home	 must	 have	 a	 ‘registered	 person’	 who	 retains	 overall	
responsibility	for	ensuring	the	effective	recording,	handling,	safe	keeping,	safe	
administration	 and	 disposal	 of	 medicines.	 In	 England,	 the	 Care	 Quality	
Commission	has	issued	quality	and	safety	guidelines	highlighting	the	provider’s	
responsibility	to	comply	with	the	regulations	of	the	Health	and	Social	Care	Act	
2008.	 The	 guidelines	 emphasise	 the	 importance	 of	 embedding	 effective	




(CIW)	 in	 order	 to	 determine	 the	 quality	 of	 medicines	 management	 and	 to	













pharmacist	 when	 the	 MAR	 chart	 is	 generated	 at	 the	 pharmacy	 as	 the	
medications	are	being	assembled	(Alldred	et	al.	2009).			
Once	 the	medication	has	been	administered	 to	 the	 resident	according	 to	 the	
date	and	time	indicated	on	the	MAR	chart,	the	MAR	charts	should	be	annotated	
to	 indicate	 an	 administration	 has	 been	 made.	 	 This	 annotation	 should	 be	
completed	 as	 soon	 as	 possible	 and	 certainly	 should	 not	 be	 left	 blank.	 If	 a	






























Somewhat	 confusingly,	 care	 homes	may	 use	 different	 letters	 with	 the	 same	
definition.		
3.1.2 The	medicines	administration	process	




labelled	 either	 as:	 (i)	 8am,	 12pm,	 4pm	 and	 8pm	 rounds	 or	 (ii)	 morning,	
afternoon,	teatime	and	bed	rounds.	Medicines	are	stored	on	a	trolley	along	with	
the	 MAR	 charts.	 	 In	 the	 majority	 of	 care	 homes	 the	 trolley	 contains	 three	
different	categories	of	medicines.	Regular	medications	in	the	form	of	tablets	and	
capsules	that	are	packed	in	a	Monitored	Dosage	System	(MDS).	This	system	was	
introduced	 in	 1990s	 to	 facilitate	 medicines	 administrations	 through	 pre-
packaged	medications	 in	 compartments	 that	 correspond	 to	 the	day	and	 time	
that	they	are	to	be	given	(Alldred	et	al.	2011).	MDS	‘trays’	are	usually	assembled	
in	the	pharmacy	and	can	be	useful	in	the	administration	process	as	it	does	not	
require	 the	 individual	 administering	 the	medicines	 to	 ‘pot	 up’	 the	 resident’s	
medicines	 from	 original	 packs.	 ‘When	 required’	medicines	 are	 stored	 on	 the	






















Having	 administered	 the	 medicines,	 it	 is	 important	 to	 document	 the	
administration.	This	should	be	completed	immediately	following	administration	
of	each	individual	dose	to	the	resident	(NICE,	2014)	and	administration	boxes	
should	 not	 be	 left	 blank	 (National	 Institute	 for	Health	 Research	 2016).	 If	 left	





















(CHUMS)	 (Alldred	et	 al.	 2009)	which	evaluated	medicines	management	 in	 55	







that	 lead	 to	medication	 errors.	 This	 was	 in	 addition	 to	 poor	 communication	





nursing	 home,	 charts	 were	 reviewed	 by	 a	 clinical	 pharmacist	 consultant	 and	






























3. To	 undertake	 a	 retrospective	 analysis	 of	 MAR	 charts	 to	 quantify	 the	
errors	identified.	


































In	 this	 study,	 the	 definition	 of	 a	medication	 error	was	 adopted	 from	 the	 US	
National	Coordinating	Council	 for	Medication	Error	Reporting	and	Prevention:	
‘Any	preventable	event	that	may	cause	or	lead	to	inappropriate	medication	use	
or	 patient	 harm	while	 the	medication	 is	 in	 the	 control	 of	 health	professional,	






used	 to	 inform	 the	development	of	a	protocol	 to	 identify	errors	were:	 (i)	1.4	


















Check	 for	 empty	 administration	 boxes,	
undefined	codes		




All	 hand-written	 changes	 on	 the	MAR	 charts	
should	be	signed	by	a	witness	
Identify	 any	 hand	 amendment	 and	 check	
for	second	signature	
Medicines	 must	 have	 clear	 instructions	 for	
administration	
Identify	 any	 medicines	 listed	 with	 as	
directed	 instructions	 or	 with	 no	
administration	instructions		




MAR	 charts	 should	 record	 the	 maximum	
frequency	of	PRN	medications	
Identify	 PRN	 medicines	 and	 check	 to	 see	
maximum	 frequency	 listed;	 for	
paracetamol	 containing	 products	 ensure	
instructions	 indicate	 minimum	 of	 4-hour	
period	between	administrations			




medicine	 for	 the	 current	 medicines	 cycle	
received	
Check	 for	 quantity	 discrepancy	 between	














to	 develop	 a	 refined	 protocol	 and	 error	 categorisation.	 This	 was	 achieved	
through	a	series	of	face-to-face	discussions	until	consensus	was	reached	within	
the	team.	After	each	meeting	the	MAR	chart	analysis	rulebook	was	updated	and	
the	MAR	 charts	 from	 Care	 Home	 0	were	 re-analysed.	N.B.	 results	 from	 Care	
Home	0	were	not	included	in	the	final	analysis.		

















The	 remaining	 nine	 care	 homes	were	 assigned	 to	 a	 separate	member	 of	 the	
research	team	(n	=	9)	and	analysed	using	the	rule	book.		This	process	was	co-
ordinated	and	overseen	by	the	author	of	this	PhD;	in	total	for	the	ten	care	homes	








coefficient	 for	 inter-rater	 reliability	 was	 not	 needed	 given	 the	 overall	
management	of	the	research	team	by	the	researcher.	






Category	 Subcategory	 Origin	of	the	error	 Example	
Regulatory	Errors	
	 1) ‘As	directed’	instruction	 Prescriber,	Pharmacy	and	CH	Staff		 As	directed	is	written	on	the	label		
	 2) Undefined	code	used	 CH	Staff	 A	code	used	is	not	defined	on	MAR	chart,	e.g.	(O)	was	written	without	clear	
definition	
	 3) Incorrect	number	of	signature	 CH	Staff	 Hand	amendment	with	insufficient	signatures,	e.g.	changes	in	the	daily	doses	was	
hand	amended	with	one	signature.		
	 4) Drug	name	misspelt	 Pharmacy	and	CH	Staff	 Incorrect	spelling	of	product	name	
	 5) No	maximum	PRN	dose	 Prescriber,	Pharmacy	 A	maximum	dose	PRN	does	not	stated	on	label	





	 1) Missed	medication	cycle	 Care	home	staff	 No	dose	is	administered	for	all	28	days,	e.g.	no	entry	on	chart	for	Furosemide.	
	 2) Omission	 	 An	administration	box	is	empty.	(Each	empty	box	is	a	separate	error)	
	 3) Deviation	from	stated	dose	 	 The	instructions	on	the	administration	label	are	not	followed.	(Each	deviation	is	a	
separate	error),	e.g.	two	doses	was	given	for	Complan	sachets	once	daily	instead	
of	one	dose	twice	a	day.	
	 4) Extra	dose	 	 An	administration	of	an	additional	dose	of	a	prescribed	medication,	e.g.	
Carbamazepine	was	given	twice	daily	instead	of	once	daily.	
	 5) Wrong	time	 	 A	dose	administered	at	different	time	from	the	prescribed	time	(±1	hr)	
e.g.	Mirtazapine	was	administered	at	tea	time	instead	of	night.	












	 2) Strength	Absent	 	 The	strength	is	completely	absent	from	the	label,	e.g.	no	strength	was	written	for	
Hyoscine	s/c	injections.	
	 3) Formulation	Absent	 	 The	formulation	is	completely	absent	from	label,	e.g.	no	formulation	was	written	
for	Mirtazpine.	
	 4) Duplicate	Entry	 	 There	is	more	than	one	entry	for	the	same	product,	e.g.	a	duplicate	entry	was	
observed	with	Carbamazepine.	
	 5) Missing	Time	 	 The	time	section	of	chart	for	administered	doses	is	not	filled	in,	e.g.	time	was	
missing	for	administration	of	Risperidone.	





	 6) Incomplete	Dosage	Information	 	 There	are	incomplete	dosage	instructions,	e.g.	no	site	of	application	for	a	cream,	
or	no	frequency	stated.	
Stock	Errors	
	 1) Quantity	Discrepancy	 CH	Staff	 The	amount	administered	exceeds	the	amount	recorded	in	stock.	
	 2) No	Date	Recorded	 	 No	date	is	recorded	for	received	stock	
	 3) No	Quantity	Recorded	 	 No	quantity	is	recorded	for	received	stock	
	 4) No	Signature	 	 No	signature	is	present	for	received	stock.	
Errors	that	cannot	be	categorised		
	 1) Miscellaneous*	 N/A	 Include	any	error	that	could	not	be	categorised	from	the	available	data,	e.g.	
Controlled	drugs	were	administered	without	second	signature.	






MAR	 charts	 were	 received	 from	 ten	 care	 homes	 comprising	 260	 unique	
residents.	 The	 MAR	 charts	 were	 reviewed	 against	 the	 validated	 protocol	
(rulebook)	 and	errors	 extracted	 and	 recorded	using	 a	data	 collection	 form	 in	
Microsoft	Excel	for	Mac	version	15.33	(Microsoft	Corporation;	Seattle,	USA).	The	
data	 collection	 form	 (see	 Appendix	 4)	 had	 fields	 for:	 care	 home	 number,	
resident	 date	 of	 birth,	 age	 in	 years,	 resident	 id	 number,	 total	 number	 of	








for	 this	 purpose.	 Descriptive	 statistics	 were	 produced	 in	 Microsoft	 Excel.		
Administration	errors	and	MAR	chart	errors	were	isolated	for	further	analysis	as	


































correct	 or	 incorrect),	 or	 the	 total	 number	 of	 errors	 (TNE;	 i.e.	 a	 dose	 can	 be	
associated	with	more	than	one	error)	(Keers	et	al.	2013a).		TNE	has	the	tendency	
to	inflate	error	rate	and	indeed	can	result	 in	error	rates	that	are	greater	than	
100%.	 Conversely	 OME	 may	 not	 capture	 the	 extent	 of	 the	 error	 because	 a	
resident	may	receive	the	wrong	drug,	at	the	wrong	strength	and	at	the	wrong	
time	but	this	would	only	be	counted	as	one	error	in	the	calculation	of	the	error	
rate.	 In	 this	 study,	 the	 TNE	 was	 used	 as	 the	 best	 compromise	 of	 the	 two	
methods.			











information	 could	 be	 gathered	 from	 the	 dosing	 instructions	 however,	 there	
were	a	number	of	caveats	where	‘workarounds’	were	needed.	These	included:		
• Commonly,	for	paracetamol	and	paracetamol	related	products,	although	






• There	 were	 cases	 where	 two	 MAR	 charts	 were	 found	 for	 the	 same	
medication(s).	It	was	clear	that	some	individuals	administered	from	the	






also	 the	 home’s	 code	 for	 nausea	 and	 vomiting.	 In	 this	 case,	 the	
researcher	used	her	own	judgement	in	counting	medicines.		




• PRN	 medications	 were	 excluded	 from	 the	 counting	 process	 because,	






the	 recruited	 care	 homes.	 This	 made	 any	 interpretation	 of	 the	
prescribers’	intention	against	the	administration	practice	flawed.	
3.3.9 Identifying	errors	with	potentially	inappropriate	medications	
Administration	 related	 errors	 associated	 with	 potentially	 inappropriate	
medications	were	extracted	from	MAR	charts.	Beers	criteria	was	used	to	classify	
medicines	as	potentially	 inappropriate.	For	a	description	of	Beers	 criteria	 see	
























1	 19	 648	 419	
2*	 21	 1369	 460	
3	 25	 1593	 707	
4	 26	 1533	 731	
5	 53	 2947	 1613	
6	 20	 1335	 401	
7	 17	 1086	 584	
8	 24	 360	 96	
9	 14	 1571	 697	
10	 41	 3820	 1062	
*17	days	of	administration	data	was	available;	for	all	other	homes	it	was	28	days.		
3.4.2 Average	number	of	errors	residents	are	exposed	to	each	week	
Given	 the	 variability	 in	 resident	 occupancy	 in	 each	 care	 home,	 the	 absolute	
number	of	errors	is	less	informative	than	the	potential	resident	exposure	to	an	
error.	Therefore,	the	number	of	errors	per	resident	per	week	was	calculated	in	
terms	 of	 the	 total	 number	 of	 errors	 identified	 in	 each	 home	 and	 the	
administration	 errors	 (see	 Table	 3.5).	 As	 can	 be	 seen,	 even	 in	 the	 best	
performing	care	homes,	a	resident	was	likely	to	be	exposed	to	four	errors	per	
week	and	in	the	poorest	performing	homes	that	rate	rises	to	28	errors	per	week.		
Not	 all	 the	 categories	 of	 errors	 pose	 an	 immediate	 risk	 to	 patient-safety,	
however,	administration	errors	are	more	likely	do	so	as	they	are	directly	patient	
facing	 and	 therefore	 an	 ‘error’	 rate	per	 resident	per	week	 for	 administration	




efficiencies	 of	 nursing	 homes	 versus	 residential	 care	 homes	 could	 not	 be	
elucidated	in	this	study.	
	 	



























































Table	 3.7	 The	 absolute	 number	 of	 medicines	 related	 errors	 identified	 in	 the	 ten	 care	 homes	
examined	in	this	study.		 
	
In	 order	 to	 better	 compare	 homes,	 the	 percentage	 of	 each	 error	 type	 was	
calculated	 from	the	 total	number	of	errors	 identified	 in	each	care	home	 (see	
Table	3.8	 and	 Figure	 3.4).	Whilst	 there	 is	 evidence	 of	 inter-home	 variability,	
some	patterns	do	emerge.	For	seven	of	the	ten	homes	(1,	3,	4,	5,	7,	8	and	9),	
	 Number	of	errors	
	 Administration	 Regulatory	 MAR	chart	 Stock		 Misc.	 Total	
Care	Home		 	 	 	 	 	 	
1	 419	 79	 20	 126	 4	 648	
2	 460	 149	 56	 593	 111	 1369	
3	 707	 124	 85	 286	 391	 1593	
4	 731	 143	 53	 339	 267	 1533	
5	 1613	 424	 164	 417	 329	 2947	
6	 401	 155	 51	 620	 108	 1335	
7	 584	 129	 37	 313	 23	 1086	
8	 96	 89	 44	 93	 38	 360	
9	 697	 206	 79	 362	 227	 1571	
10	 1062	 246	 141	 588	 1783	 3820	






-	 65%).	 For	 the	 remaining	 three	 homes,	 stock	 was	 the	 most	 frequently	
encountered	error	in	two	homes	(homes	2	and	6)	and	miscellaneous	errors	was	
the	most	common	error	category	 in	care	home	10.	 	 In	the	majority	of	homes	
(8/10),	 MAR	 chart	 errors	 (errors	 associated	 with	 incomplete	 or	 absent	
information	on	the	MAR	chart)	were	the	least	commonly	encountered	errors.			
Table	3.8	Percentage	breakdown	of	each	error	type	for	each	care	home.	In	seven	of	the	ten	care	































% of Regulatory errors
% of Administration errors
% of MAR chart errors
% of Stock errors
% of Miscellaneous errors
	 Care	Home	Number	
Errors	(%	of	total)	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
1. Regulatory	 12	 11	 8	 9	 14	 12	 12	 25	 13	 6	
2. Administration		 65	 34	 44	 48	 55	 30	 54	 27	 44	 28	
3. MAR	chart		 3	 4	 5	 3	 6	 4	 3	 12	 5	 4	
4. Stock	 19	 43	 18	 22	 14	 46	 29	 26	 23	 15	
5. Miscellaneous		 1	 8	 25	 17	 11	 8	 2	 11	 14	 47	










Administration	 errors	were	 broken	 down	 into	 six	 subcategories:	 (i)	 deviation	
from	the	stated	dose;	(ii)	a	missed	medicines	cycle;	(iii)	an	omitted	dose;	(iv)	an	
extra	dose;	(v)	dose	administered	at	the	wrong	time	and	(vi)	an	administration	






was	 5%	 (in	 care	 home	 6)	 up	 to	 99%	 (in	 care	 home	 9).	 A	 number	 of	 the	
subcategories	were	not	associated	with	high	levels	of	error	 in	any	of	the	care	
homes	 studied.	 Deviation	 from	 the	 stated	 dose	 (range	 0	 –	 3%)	 and	 an	
unexplained	 crossing	 out	 of	 an	 administration	 (range	 0.4%	 to	 2%)	 were	
particularly	uncommon	both	in	terms	of	the	absolute	number	of	errors	identified	
(data	not	 shown)	 and	 their	 contribution	 to	 the	 administration	error	 category	
within	each	home	as	a	whole.		An	unexplained	missed	medication	cycle	(i.e.	a	
resident	did	not	receive	one	or	more	medicines	for	the	entirety	of	a	28-day	cycle)	




















The	MAR	chart	error	category	was	comprised	of	 six	 sub-categories	 related	 to	
either	missing	information	about	the	drug	or	a	duplicate	entry	for	a	drug	on	the	
























r Deviation from stated dose






Administration	Errors	%	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
Deviation	from	stated	
dose	
1	 0	 0	 0	 0.1	 0.5	 0	 0	 0	 3	
Missed	medication	cycle		 6	 2	 0	 2	 2.9	 0	 5	 13	 0	 0	
Omitted	dose		 45	 86	 91	 64	 82	 5	 84	 84	 99	 94	
Extra	dose	 40	 5	 2	 17	 11	 29	 10	 1	 0.1	 2	
Wrong	time		 7	 5	 6	 15	 3	 64	 0.1	 0	 0	 0.6	
Crossing	out	 1	 2	 1	 2	 1	 1.5	 0.9	 2	 0.9	 0.4	
Absolute	No	of	errors	 419	 460	 707	 731	 1613	 401	 584	 96	 697	 1062	





was	 absent;	 (iv)	 the	 required	 time	 of	 the	 administration	was	 absent;	 (v)	 the	
dosing	 information	 was	 absent	 or	 (vi)	 the	 MAR	 chart(s)	 for	 the	 resident	
contained	a	duplicated	medication.	Whilst	the	absolute	number	of	MAR	chart	
errors	identified	in	the	care	homes	was	relatively	small	(20	–	164	errors;	range	3	
–	 12%	 of	 all	 errors	 identified	 in	 each	 home;	 see	 Table	 3.10	 and	 Figure	 3.6)	
nevertheless	 such	 errors	 are	 associated	 with	 risk	 to	 the	 patient.	 With	 the	
exception	of	 care	home	1,	 there	were	examples	 in	all	 care	homes	where	 the	
dosage	instructions	were	incomplete	on	the	MAR	chart.	Indeed,	in	care	home	6	
some	43	of	 the	 51	MAR	 chart	 errors	 (84%)	were	 associated	with	 incomplete	
information.	Similarly,	with	 the	exception	of	care	homes	4	and	7,	 there	were	















MAR	chart	Errors	(%)	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
Dose	absent	 75	 11	 2	 0	 18	 8	 0	 36	 2	 50	
Formulation	absent		 0	 9	 2	 40	 26	 0	 19	 36	 0	 0	
Strength	absent	 5	 4	 4	 3	 10	 8	 0	 8	 0	 3	
Missing	time		 15	 18	 29	 21	 2	 0	 30	 0	 54	 23	
Duplicate	medication	 5	 13	 19	 6	 16	 0	 5	 0	 0	 1	
Incomplete	dosage	
information		
0	 45	 44	 30	 28	 84	 46	 20	 44	 23	
Absolute	No	of	errors	 20	 56	 85	 53	 164	 51	 37	 44	 79	 141	










or	guidance.	 In	 this	case,	 the	regulatory	errors	category	was	comprised	of	six	
sub-categories:	(i)	medicines	written	up	with	‘as	directed’	directions;	(ii)	missing	
chart	 information	 (e.g.	DOB,	allergy	 status);	 (iii)	no	maximum	dose	stated	 for	















































home	 making	 a	 clinical	 decision	 on	 how	 and	 when	 it	 the	 medicine	 be	
administered.	 Similarly,	 in	 8/10	 homes,	 there	 were	 examples	 where	 ‘when	
required’	medicines	did	not	have	a	maximum	dose	stated.	This	relies	on	those	






































Regulatory	errors	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
As	directed		 32	 8	 18	 3	 10	 14	 7	 7	 5	 29	
Missing	chart	information		 20	 23	 9	 23	 36	 7	 14	 30	 3	 5	
No	maximum	prn	dose	 0	 11	 11	 8	 1	 3	 0	 1	 4	 6	
Drug	name	misspelt		 0	 0	 0	 2	 1	 2	 0	 2	 0	 0	
Missing	signature	 28	 30	 35	 54	 36	 43	 74	 34	 32	 22	
Undefined	code		 20	 28	 27	 10	 16	 31	 5	 26	 56	 38	
Absolute	number	of	errors	 79	 149	 124	 143	 424	 155	 129	 89	 206	 246	





It	 is	 a	 regulatory	 guidance	 that	 the	 hand	 amendment	 related	 to	 changes	 in	
dosing	or	any	instruction	of	medications	should	be	signed	by	two	members	of	
staff	 on	 the	MAR	 chart.	 However,	 in	 all	 care	 homes	 there	 was	 a	 significant	






























accounted	 for	 appropriately,	 it	 may	 for	 example	 run	 out	 prematurely	 which	
















were	 a	 fairly	 significant	 number	 of	 instances	 where	 the	 quantity	 of	 stock	












Stock	errors	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
No	date	recorded		 41	 31	 32	 74	 31	 33	 49	 37	 49	 44	
No	quantity	recorded		 2	 31	 26	 10	 29	 34	 2	 22	 0.3	 2	
No	signature	recorded	 40	 31	 34	 14	 31	 33	 49	 36	 42	 36	
Quantity	discrepancy		 17	 7	 8	 2	 9	 0.3	 0	 5	 9	 18	
Absolute	number	of	errors	 126	 593	 286	 399	 417	 620	 313	 93	 362	 588	










errors	 in	 care	 homes	 is	 associated	 with	 the	 total	 number	 of	 medicines	
administered	 (Barber	 et	 al.	 2009b).	 A	 Pearson	 correlation	 co-efficient	 was	
therefore	calculated	for	the	total	number	of	medicines	administered	versus	the	
frequency	of	(i)	administration	errors;	(ii)	MAR	chart	errors;	(iii)	regulatory	errors	










Administration	errors	 0.7452	 0.0134	 Strong	 Positive	
MAR	chart	errors	 0.848	 0.0019	 Strong	 Positive	
Regulatory	errors	 0.6962	 0.0253	 Moderate	 Positive	

































The	 analysis	 revealed	 a	 statistically	 significant	 strong	 positive	 relationship	
between	 the	 total	 number	 of	 medicines	 administered	 and	 the	 number	 of	
administration	errors	(r	=	0.7452;	p	=	0.0134)	and	MAR	chart	errors	(r	=	0.848;	
p	 =	 0.0019).	 A	 statistically	 significant	moderate	 positive	 correlation	was	 also	
observed	between	total	number	of	medicines	administered	and	the	number	of	
regulatory	errors	identified	(r	=	0.6962;	p	=	0.0253).	However,	for	stock	errors,	
there	 was	 no	 statistically	 significant	 correlation	 between	 total	 number	 of	
medicines	administered	and	the	number	of	stock	errors	identified.		
3.4.7 Medication	errors	associated	with	potentially	inappropriate	medicines	
Given	 the	high	prevalence	of	prescribing	of	PIMs	 identified	 in	 this	 study	 (see	
Chapter	2)	an	analysis	of	the	administration	and	MAR	chart	errors	associated	
with	such	medicines	was	undertaken.	Table	3.15	shows	the	number	of	residents	
across	 the	 ten	 care	 homes	 that	 were	 exposed	 to	 an	 administration	 error	
associated	with	their	PIM	and	the	number	of	 residents	 that	had	a	MAR	chart	
error	 associated	 with	 their	 PIM;	 some	 residents	 may	 have	 had	 both	 an	
administration	error	and	a	MAR	chart	error	associated	with	their	PIM.		As	can	be	
seen,	with	 the	exception	of	 the	cardiac	glycosides,	 there	were	 residents	with	
administration	errors	in	all	categories	of	PIMs.		In	terms	of	MAR	chart	errors,	the	
number	 of	 residents	 with	 a	 MAR	 chart	 error	 associated	 with	 their	 PIM	 was	
significantly	 lower	 and	 indeed,	 no	 MAR	 chart	 errors	 were	 identified	 for	
hypnotics,	potassium	sparing	diuretics,	NSAIDs,	SNRIs,	SSRIs,	thiazide	diuretics	
or	drugs	used	to	treat	urinary	tract	infections.	A	substantial	number	of	residents	
were	 exposed	 to	 administration	 errors	 associated	 with	 their	 PIM.	 This	 was	
particularly	prevalent	for	antiplatelets	(23	residents,	33.8%),	antipsychotics	(37	
residents,	44.6%)	drugs	for	the	control	of	epilepsy	(7	residents	53.8%),	and	other	
antidepressants	 (11	 residents,	 50%);	 the	 prevalence	 was	 high	 for	 other	
categories	 but	 the	 analysis	 is	 not	 robust	 given	 the	 low	 number	 of	 residents	
receiving	such	medicines.	











Antihistamine	 2	 0	(0.00%)	 0	(0.00%)	
Antiplatelet	 68	 23	(33.8%)	 2	(2.9%)	
Antipsychotic	 83	 37	(44.6%)	 4	(4.8%)	
Antispasmodic	 6	 2	(33.3%)	 1	(16.7%)	
Anxiolytic	 58	 16	(27.6%)	 1	(1.7%)	
Cardiac	glycoside	 2	 0	(0.00%)	 2	(100%)	
Control	of	epilepsy	 13	 7	(53.8%)	 2	(15.4%)	
Hypnotic	 62	 12	(19.4%)	 0	(0%)	
Insulin	 3	 1	(33.35)	 2	(66.7%)	
K	sparing	diuretic	 5	 1	(20.0%)	 0	(0%)	
Loop	diuretic	 43	 10	(23.3%)	 5	(11.6%)	
NSAIDs	 7	 2	(28.6%)	 0	(0%)	
Other	antidepressants	 22	 11	(50.0%)	 1	(4.5%)	
PPIs	 105	 23	(21.9%)	 2	(1.9%)	
SNRIs	 9	 4	(44.4%)	 0	(0%)	
SSRIs	 38	 8	(21.1%)	 0	(0%)	
TCA	 6	 2	(33.3%)	 1	(16.7%)	
Thiazide	diuretic	 6	 1	(16.7%)	 0	(0%)	
Urinary	tract	infection	 5	 3	(60.0)	 0	(0%)	





A	 breakdown	of	 the	 administration	 errors	 associated	with	 PIMs	 categories	 is	
provided	in	Table	3.16.	Dose	omission	was	the	most	frequent	error	identified	in	
almost	all	class	of	PIMs	and	the	prevalence	was	particularly	high	for	antiplatelets	















PIM	 Deviation	from	stated	dose	 Missed	medication	cycle	 Omitted	dose		 Extra	dose	 Wrong	time	 Crossing	out	
Antihistamine	 0	 0	 0	 0	 0	 0	
Antiplatelet	 0	 1	 47	 1	 22	 1	
Antipsychotic	 0	 0	 147	 9	 0	 3	
Antispasmodic	 2	 0	 26	 0	 1	 0	
Anxiolytic	 0	 0	 119	 3	 31	 1	
Cardiac	glycoside	 0	 0	 0	 0	 0	 0	
Control	of	epilepsies	 0	 0	 13	 1	 27	 0	
Hypnotic	 0	 0	 49	 0	 28	 0	
Insulin	 	0	 0	 1	 0	 0	 0	
K	sparing	diuretic	 0	 1	 0	 0	 0	 0	
Loop	diuretic	 0	 1	 21	 2	 28	 1	
NSAIDs	 0	 0	 15	 0	 0	 0	
Other	antidepressants	 0	 0	 15	 0	 28	 1	
PPIs	 0	 1	 64	 29	 2	 0	
SNRIs	 0	 0	 23	 1	 26	 0	
SSRIs	 0	 0	 14	 0	 0	 1	
TCA	 0	 0	 2	 0	 0	 0	
Thiazide	diuretic	 0	 0	 1	 0	 0	 0	
Urinary	tract	infection	 0	 0	 5	 0	 0	 1	
	








A	 retrospective	 analysis	 of	 paper-based	 medication	 administration	 records	
(MAR	charts)	was	undertaken	in	ten	care	homes	in	the	South	Wales	region	to	
explore	 the	 nature	 and	 extent	 of	 errors	 related	 to	 medicines	 management.	
Medicines	management	was	used	here	in	the	broadest	context	from	the	receipt	
of	stock	through	to	the	administration	of	medicines	to	residents.		A	total	of	25	
distinct	 errors	 types	 were	 identified	 that	 were	 categorised	 into	 five	 main	
categories:	(i)	administration	errors;	(ii)	MAR	charts	errors;	(iii)	regulatory	errors;	
(iv)	stock	errors	and	(v)	miscellaneous	errors	that	could	not	be	assessed	without	








There	 are	 a	 variety	 of	methodologies	 that	 can	 be	 used	 to	 identify	medicines	
errors	 in	 health	 and	 social	 care	 settings	 including	 patient	 monitoring,	 chart	
review,	analysis	of	computer	records,	observation,	error	reporting,	and	claims	
data	 (Montesi	 and	 Lechi	 2009).	 Each	of	 these	methodologies	 have	 their	 own	
advantages	and	disadvantages.	For	example,	the	direct	observation	of	patient	
care	 is	 accurate	 and	 effective	 in	 capturing	 active	 errors.	 However,	 it	 is	 time	
consuming,	difficult	 to	scale,	 requires	significant	training	of	 the	observer	who	
must	 normally	 belong	 to	 the	 same	professional	 group	 that	 are	 administering	
care	(Flynn	et	al.	2002;	Michel	2004)	and	is	liable	to	the	Hawthorne	effect	i.e.	
the	 observer	 modifies	 their	 behavior/actions	 as	 a	 consequence	 of	 being	
observed	(McCarney	et	al.	2007).	Chart	review	on	the	other	hand	is	a	commonly	
used	method	 to	 retrospectively	 analyse	 data	 sources	 such	 as	medical	 charts,	


















Incident	 database	 (iii)	 Complaints	 database	 (iv)	 Claims	 database;	 (v)	 Inquest	
database;	(vi)	the	Patient	Administration	System	and	(vii)	case	notes.	Case	notes	




to	 compare	 studies	 (Keers	 et	 al.	 2013b).	 To	 summarise,	 whilst	 any	 one	
methodology	will	capture	a	particular	range	of	errors	it	will	not	capture	all	errors	
in	 the	 setting	 and	 wherever	 possible	 a	 range	 of	 methodologies	 should	 be	
employed.		
In	 this	 study,	 MAR	 charts	 represented	 an	 accessible	 data	 source	 for	 the	
identification	of	medicines	related	errors	in	care	homes.	The	researcher	could	
find	 only	 one	 other	 study	 in	 the	 literature	 that	 used	MAR	 charts	 to	 identify	
medication	errors	in	nursing	home.	The	study,	published	in	the	US	in	1979	aimed	
to	 identify	 documentary	 issues	with	MAR	 charts.	 	 The	 process	 involved	 four	
members	of	staff	reviewing	15	MAR	charts	over	a	four-month	period	to	identify	
any	errors	in	the	documentation	using	a	protocol	that	was	developed	in	house.	
The	 study	 revealed	15	 types	of	errors	 related	 to	 the	documentation	 some	of	
which	were	similar	to	this	current	study	(Krikorian	1979).		













administered	 at	 the	 wrong	 time	 and	 deviations	 from	 the	 prn	 protocol)	 are	
directly	patient	facing	and	have	the	greatest	potential	to	cause	patient	harm.	As	
such,	administration	errors	were	examined	in	some	detail	and	were	found	to	be	
the	 most	 common	 error	 type	 identified	 in	 seven	 of	 the	 ten	 care	 homes	
investigated.	 This	 finding	 is	 consistent	with	 other	 studies	 that	 have	 reported	
medication	administration	errors	 as	 the	main	 source	of	 errors	 in	 care	homes	
(Alldred	et	al.	2009;	Crespin	et	al.	2010;	Greene	et	al.	2010;	Lane	et	al.	2014;	
Pierson	et	al.	2007)	and	indeed	other	health	care	settings	(Ghaleb	et	al.	2010;	
Haw	 et	 al.	 2007;	 Kelly	 et	 al.	 2011;	 Keers	 et	 al.	 2013a;	 McLeod	 et	 al.	 2015;	







administration	 errors	 per	 resident	 per	 week	 was	 calculated.	 On	 average,	
residents	 were	 exposed	 to	 6	 (±3)	 administration	 errors	 per	 week	 and	 the	
prevalence	of	administration	errors	by	opportunity	was	8.6%	(±0.03).	 	 	 In	 the	
seminal	 CHUMs	 study	 (Alldred	 et	 al.	 2009),	 256	 residents	 had	 two	 of	 their	
medicines	rounds	observed	to	identify	administration	errors.	The	prevalence	of	
administration	 errors	 by	 total	 opportunities	 was	 8.4%	 which	 is	 remarkably	
similar	to	the	findings	in	this	current	study.		Whilst	the	approach	of	reviewing	
MAR	 charts	 to	 identify	 administration	 errors	 in	 this	 study	 showed	 good	







alignment	 with	 the	 CHUMs	 study,	 Richard	 and	 colleagues	 reported	 an	
administration	error	rate	of	0.2%	using	chart	review	compared	to	10%	with	an	





cursory	 review	which	might	 lead	 to	 underestimation	 of	 errors	 that	 could	 be	
identified	through	MAR	charts.	(Shannon	and	De	Muth	1987).			
In	 common	 with	 the	 CHUMS	 study	 (and	 that	 of	 others	 (Pierson	 et	 al	 2007;	
Greene	 et	 al.	 2010),	 omitted	 doses	 were	 the	 most	 frequently	 encountered	
administration	error	 in	 this	current	study	accounting	 for	an	average	of	73.4%	
(data	not	shown)	of	the	administration	errors	across	the	ten	homes	compared	
for	 example	 to	 49.1%	 in	 the	CHUMS	 study.	 The	 reason	 for	 dose	omissions	 is	
multifactorial.	 There	 are	 human	 factors	 for	 example	 interruptions	 during	 the	
administration	 rounds	 and	 medicines	 related	 factors	 for	 example	 the	
unavailability	of	medications	at	the	time	of	administration.		
In	a	number	of	homes,	and	particularly	in	care	home	6,	there	was	evidence	of	






to	 cause	 resident	 harm,	 ultimately	 it	 contravenes	 the	prescriber’s	 intentions.	
There	 is	 a	 paucity	 of	 literature	 exploring	 the	 reason	 for	 such	 changes	 to	 the	
scheduled	 administration	 time	 and	 it	 is	 likely	 to	 be	 multifactorial	 however	
possible	reasons	might	include:	(i)	the	prescriber	has	changed	the	administration	
schedule	but	the	chart	has	not	been	updated,	 (ii)	somebody	 in	the	home	has	


















The	 number	 of	 care	 homes	 within	 the	 study	 was	 too	 low	 to	make	 any	 firm	
conclusions	 on	 whether	 errors	 were	 higher	 in	 nursing	 homes	 compared	 to	
residential	homes.	In	terms	of	exposure	of	patients	to	administration	errors,	care	
home	 8	 (a	 residential	 home)	 was	 the	 best	 performing	 home	 with	 just	 one	
administration	error	per	 resident	per	week.	The	other	 residential	home,	 care	
home	1,	sat	at	the	average	with	six	administration	errors	per	week.	It	might	have	
been	 expected	 that	 nursing	 homes	 deliver	 better	 quality	 of	 medicines	
administration	because	of	the	higher	standard	of	professional	training	received	
by	 nurses	 (c.f.	 carers	 in	 residential	 homes)	 however	 there	 is	 evidence	 in	 the	
literature	to	suggest	that	this	is	not	the	case	(Scott-Cawiezell	et	al.	2007)	with	
residential	homes	having	a	lower	prevalence	of	medication	errors.	This	is	partly	






an	 improved	 trend	 in	 the	 performance	 of	 residential	 homes	 against	 quality	










From	 the	 total	 6770	 administration	 errors	 identified	 in	 this	 study,	 816	 (12%)	
were	 related	 to	 PIMs,	 while	 only	 39	 (5%)	 of	 the	 MAR	 chart	 errors	 were	
associated	 with	 PIMs	 from	 a	 total	 of	 730	 errors.	 The	 prevalence	 of	
administration	errors	associated	with	PIMs	was	particularly	high	for	drugs	that	
act	 in	the	CNS	system	(antipsychotics,	drugs	for	the	control	of	epilepsy,	other	
antidepressants)	 and	 antiplatelets.	 In	 the	 main,	 these	 administration	 errors	
were	associated	with	omitted	doses	which	can	lead	to	preventable	adverse	drug	
reactions	and	serious	patient	safety	issues	(Handler	et	al.	2006).		To	the	best	of	








85%	 of	 these	 preventable	 adverse	 events	 were	 related	 to	medication	 errors	




The	 reasons	 that	administration	errors	occur	 is	 likely	 to	be	multifactorial	and	
may	be	as	a	consequence	of	‘follow	through	errors’	arising	from	errors	made	by	
the	 prescriber	 or	 at	 the	 pharmacy,	 they	 may	 be	 due	 to	 the	 individual	
administering	 the	 medicine	 or	 may	 be	 influenced	 by	 the	 patient	 /	 resident.		
Hughes	and	Ortiz	have	suggested	four	lines	of	defence	in	preventing	medication	


















received	 from	 the	 pharmacy	 or	 the	 medication	 is	 unavailable	 and	 (vii)	
documentation	 contains	 inadequate	 or	 inaccurate	 information.	 Dilles	 and	
colleagues	sought	to	codify	the	barriers	to	effective	medicines	management	in	
nursing	homes,	focusing	particularly	on	the	experience	of	nurses,	and	identified	
four	 domains	 (i)	 nurses;	 (ii)	 interdisciplinary	 co-operation;	 (iii)	 organisational	
structure	and	culture	and	(iv)	patient	and	family	(Dilles	et	al.	2011).		The	nurse	
related	 factors	 included	 a	 lack	 of	 knowledge	 of	 therapeutics,	 attitudinal	
problems	 and	 a	 sense	 of	 not	 understanding	 how	 far	 their	 responsibility	 for	
administrations	 reaches	 (this	 was	 particularly	 true	 for	 the	 monitoring	 phase	
following	 administration).	 	 In	 terms	 of	 interdisciplinary	 cooperation,	 lack	 of	
communication	between	staff	in	the	home,	poor	accessibility	to	prescribers	and	
pharmacists,	 problems	 in	 the	 legibility	 and	 completeness	 of	 documentary	
information	 and	 poor	 definition	 of	 the	 tasks	 to	 be	 completed	 were	 cited	 as	
barriers	 to	 effective	 medicines	 management.	 The	 organizational	 issues	 were	
similar	 to	 those	 seen	 in	 other	 industries,	 high	 workload,	 staff	 shortages	



















and	 nursing	 home	 setting	 they	 have	 been	 shown	 to	 increase	 the	 number	 of	
administration	errors	(Scott-Cawiezell	et	al.	2007;	Biron	2009;	Westbrook	et	al.	
2010)	.	There	are	essentially	two	sources	of	interruptions	which	might	lead	to	a	




and	 distractions	 should	 be	 kept	 to	 a	minimum	 during	 administration	 rounds	
(NICE	2014).	Whilst	to	date	there	have	been	no	observational	studies	that	have	
sought	 to	determine	 the	 impact	of	 interventions	 to	minimise	 interruptions,	a	
number	 of	 studies	 have	 suggested	 that	 training	 to	 enable	 nurses/carers	 to	




care	 homes	 (Hinchliffe	 A.	 2010;	 Dilles	 et	 al.	 2011).	 These	 staffs	 are	 usually	
inexperienced,	 have	 a	 lack	 of	 knowledge	 and	 thus	 are	 more	 likely	 to	 make	
mistakes	during	 the	administration	process.	NICE	Guidelines	 recommend	that	
skilled	and	trained	staffs	should	be	put	on	duty	and	planned	staff	breaks	should	
be	 avoided	during	medicines	 administration	 round	 (NICE	2015).	 Indeed,	 Care	
Inspectorate	Wales	 (Care	 Inspectorate	Wales	 2014),	 has	 a	 national	minimum	












Inspectorate	Wales	 2014).	 Adequate	 staffing	 is	 required	 to	 ensure	medicines	
administration	is	carried	out	properly	and	to	provide	good	care	to	the	resident.	
Studies	do	suggest	that	shortages	of	personnel	are	likely	to	increase	the	number	




training	were	 said	 to	 contribute	 to	 the	 high	 prevalence	 of	medication	 errors	
(Smith	2004;	Vaismoradi	et	al.	2014).		




flexibility	when	medicines	 or	 their	 doses	 are	 changed	mid-cycle	 (Alldred	 and	
Standage	 2011).	 Of	 note,	 there	 is	 little	 evidence	 to	 suggest	 MDS	 is	 a	 safer	
method	of	administration	compared	to	using	original	packs	(Alldred	et	al.	2009).	
It	does	however	increase	the	workload	demands	on	the	pharmacy	and	in	order	
to	 repackage	medicines	 at	 scale,	MDS	pharmacy	hubs	 are	 created	which	 can	
decrease	the	interdisciplinary	collaboration	with	the	home	as	the	hub	is	often	
more	 remote	 that	 the	 local	 pharmacy	 (Alldred	et	 al.	 2009).	 In	 addition,	 even	
where	 MDS	 systems	 are	 in	 place,	 medications	 such	 as	 oral	 liquid,	 inhalers,	
eye/ear	 drops	 and	 powders	 cannot	 be	 put	 in	 the	 MDS	 compartments	 and	
therefore	 arrive	 at	 the	 home	 in	 their	 original	 packing.	 This	 requires	 two	























instructions	 are	 present	 on	 the	 MAR	 chart	 and	 that	 those	 individuals	
administering	 the	 medicines	 fully	 understand	 the	 instructions.	 There	 were	
occasions	where	a	resident	was	potentially	put	at	risk	due	to	insufficient	dosage	





In	 the	 main,	 the	 errors	 were	 associated	 with	 either	 the	 absence	 of	 a	 dose,	
incomplete	 dosage	 information	 or	 there	 was	 no	 scheduled	 time	 for	 the	
administration;	missing	 formulation	details	and	absence	of	a	 strength	 for	 the	
medicine(s)	was	 less	common.	 It	 is	worth	reiterating	that	the	MAR	charts	are	
generated	in	the	pharmacy	based	on	the	resident’s	prescription	and	therefore	







the	 source	 of	 the	 error	 is	 at	 the	 pharmacy.	 Nevertheless,	 from	 a	 regulatory	
perspective	 it	 is	 the	 responsibility	 of	 the	 home	 to	 ensure	 the	 MAR	 chart	 is	
accurate	and	complete.	Ultimately,	these	MAR	chart	errors	betray	a	failure	 in	
the	 systems	 and	 processes	 from	 the	 prescriber	 through	 to	 the	 home.	 The	
prescriber	 should	 ensure	 the	 prescription	 is	 complete,	 where	 it	 is	 not,	 the	
pharmacist	should	liaise	with	the	prescriber	to	rectify	any	missing	information	
and	 if	 that	slips	 through	on	the	MAR	chart	 the	home	should	engage	with	the	
pharmacist	 and/or	 prescriber	 to	 update	 the	MAR	 chart.	 Such	 errors	 are	 not	
unique	to	the	care	home	setting.	In	the	Institution	of	Medicine’s	(IOM)	report,	
‘Preventing	Medication	Errors’	 (Bates	2007),	 inappropriate	 labelling	has	been	
cited	as	a	cause	of	medication	errors	that	may	contribute	to	the	occurrence	of	














There	 is	 an	 opportunity	 for	 pharmacists	 to	 play	 a	 greater	 role	 here.	 Beyond	
ensuring	that	MAR	charts	are	complete	and	accurate,	pharmacists	can	play	a	role	
in	 education	 and	 training	 and	medicines	 reviews	 at	 the	 care	 home.	 In	 2006,	
Zermansky	 and	 colleagues	 suggested	 that	 pharmacists	 can	play	 an	 important	



















be	 resolved	 at	 the	 pharmacy	 before	 the	 MAR	 chart	 arrives	 at	 the	 home.	
Nevertheless,	the	home	should	seek	to	rectify	such	errors	with	the	prescriber	or	
pharmacist	 as	 soon	 as	 it	 is	 identified.	 In	 contrast	 errors	 in	 the	 remaining	







It	 was	 clear	 from	 the	 review	 of	 MAR	 charts	 that	 there	 were	 a	 lot	 of	 hand	
amendments	to	the	charts	and	these	did	not	always	have	signature	or	the	name	
of	prescriber	who	 instigated	or	authorised	the	changes.	The	use	of	undefined	
codes	 contravenes	 regulatory	 guidance	 (NICE	 2015)	 but	 is	 perhaps	 a	
consequence	of	local	practices	that	are	established	due	to	incomplete	and	non-
standardised	processes	within	the	sector	(Dilles	et	al.	2011).			









to	 be	 a	 contributor	 to	medicines	 administration	 errors	 (omission	 and	wrong	
time)	in	the	secondary	care		setting	(Dean	et	al.	1995;	Ho	et	al.	1997;	Taxis	et	al.	
1999).	 Many	 of	 the	 medications	 received	 had	 no	 indication	 of	 ‘booked	 in’	
quantities,	 the	 date	 received	 or	 a	 signature	 to	 indicate	who	 receipted	 them.	
Together	 these	 can	 lead	 to	 errors	 in	 stock	management	 that	may	 result	 in	 a	
medication	 being	 unavailable	 for	 a	 resident	 at	 the	 point	 of	 administration.	
Where	 this	 is	associated	with	an	MDS	 tray	 it	may	be	 that	 the	entirety	of	 the	
resident’s	medicines	 is	missing.	 	 In	 addition,	 there	were	 discrepancies	 in	 the	
quantity	 received	 compared	 to	 the	 actual	 number	 of	 administration	 events	
indicated	on	 the	MAR	chart.	 	Again,	 this	may	 increase	 the	 risk	of	 a	medicine	
running	 out	 leading	 to	 an	 avoidable	 delay	 in	 administration	 to	 the	 resident.	












scope	 of	 this	 thesis	 and	 indeed	 could	 not	 be	 addressed	 through	MAR	 chart	
analysis.		
	







In	 summary,	 this	 study	has	explored	 the	nature	and	prevalence	of	medicines	
management	 errors	 in	 care	 homes	 through	 a	 retrospective	 analysis	 of	 MAR	
charts.	The	number	of	errors	 identified	was	 significant	and	 in	 line	with	 those	
identified	 in	 the	 seminal	 CHUMS	 study	 (Alldred	 et	 al.	 2009).	 Medicines	
administration	errors	were	particularly	prevalent	and	this	was	primarily	related	
to	 dose	 omissions.	Whilst	 it	was	 beyond	 the	 scope	 of	 this	 study,	 the	 clinical	
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Medicines	 play	 an	 important	 role	 in	 improving	 the	 health	 and	 wellbeing	 of	















compared	 to	 22.3	 in	Northern	 Ireland,	 20.0	 in	 England	 and	 19.2	 in	 Scotland).	





the	 NHS	 by	 preventing	 the	 use	 of	 alternative	 interventions	 (for	 example	 an	
unintended	 A&E	 visit	 or	 hospital	 admission)	 which	 are	 more	 costly	 than	
medicines	 (NICE	 2015).	 However,	 as	 has	 been	 described	 in	 Chapters	 2	 &	 3,	









them	 properly	 which	 results	 in	 waste	 of	 healthcare	 resources	 (World	 Health	
Organisation	2016).	The	scale	of	the	problem	is	significant	with	WHO	estimating	





authors	 use	 similar	 but	 subtly	 different	 definitions	 (White	 2010;	 	 Abou-Auda	
2003;	 York	 Health	 Economics	 Consort	 and	 The	 School	 of	 Pharmacy	 2010),	
medicines	 waste	 is	 categorised	 by	 the	 supply	 of	 prescription	 medicines	 to	
patients	 that	 are	 ultimately	 discarded.	 In	 the	 seminal	 ‘York	 Study’	 titled	
“Evaluation	of	the	scale,	causes	and	costs	of	waste	medicines”	by	the	York	Health	
Economics	Consortium	and	 the	 School	 of	 Pharmacy,	UCL	medicine	waste	was	
defined	as	“drugs	that	are	dispensed	but	are	ultimately	physically	discarded.	That	
is,	they	are	put	into	domestic	waste	or	the	drains,	or	returned	to	pharmacists	or	
dispensing	doctors	 for	 incineration.”	 This	definition	was	developed	out	of	 the	
European	 Waste	 Framework	 Directive	 (2008)	 that	 defines	 waste	 as	 ‘any	


























date	 on	 the	 medicine	 has	 been	 achieved.	 The	 authors	 used	 a	 different	
methodological	 approach	 to	 that	 of	 the	 OPCS.	 They	 developed	 a	 telephone	
survey	 with	 a	 target	 (arbitrary)	 of	 1000	 responses	 (1185	 actual)	 and	 audited	
medicines	returned	to	114	community	pharmacies	across	five	primary	care	trusts	
in	England;	the	audit	also	included	medicines	returned	from	care	homes.		From	




Consort	 and	 The	 School	 of	 Pharmacy	 2010).	 Put	 another	 way,	 these	 wasted	
medicines	account	for	£1	of	in	every	£25	spent	on	prescribed	medicines	or	0.3%	
of	overall	NHS	spend.	The	authors	concluded	that	the	scale	of	medicines	waste	is	
likely	 to	 be	 underestimated	 as	 a	 consequence	 of	 the	 survey	 methodology	











There	 are	 several	 key	 consequences	 of	 medicines	 waste	 for	 patients,	
practitioners,	 healthcare	 organisations	 and	 society.	 Such	wastage	 imposes	 an	
economic	burdens	in	terms	of	direct	expenses	as	a	consequence	of	the	cost	of	








medication)	 and	 those	 that	 are	 avoidable	 (repeat	 dispensing,	 stock	 piling	 and	






staff	 were	 not	 confident	 with	 the	 administration	 of	 some	 medications	
(particularly	‘when	required’	medicines)	or	familiar	with	the	clinical	condition	of	









the	 disposal	 of	 some	medicines;	 	 (iii)	 receiving	 the	 wrong	medication	 due	 to	
errors	 in	prescribing	or	dispensing	of	medicines	(Bristol	Clinical	Commissioning	
Group	2016).		






















Patient	recovery	 A	 patient	 may	 recover	 from	 a	 condition	 before	 the	 stock	 of	 the	 medicine	 treating	 the	 condition	 is	 fully	
consumed.	Any	remaining	medicines	stock	is	waste.		
(Coma	et	al.	2008)	



















In	2014,	West	and	colleagues	 conducted	a	 systematic	 review	of	 the	 literature	
related	 to	 medicine	 waste	 (West	 et	 al.	 2014).	 The	 authors	 retrieved	 14,157	
papers	related	to	waste	and	screened	this	down	to	42	papers.	The	authors	noted	
that	 there	 was	 a	 discrepancy	 in	 what	 constituted	 medicines	 waste	 between	
papers	which	made	 comparison	 difficult.	 However,	 the	most	 commonly	 cited	
reasons	 for	 medicines	 waste	 were:	 	 (i)	 medication	 changed	 (Morgan	





it’s	 contributory	 factors.	 Using	 an	 expert	 panel	 of	 academics,	 practitioners,	
government	 officials,	 representatives	 from	 professional	 organisations	 and	
patients	situated	in	Malta,	the	authors	identified	four	main	contributory	factors:	
(i)	 physical	 and	 environmental	 factors;	 (ii)	 social	 and	 psychological	 patient	
factors;	(iii)	cultural	factors	and	(iv)	practitioner	factors.	Each	of	these	factors	was	






















The	 York	 study	 (York	 Health	 Economics	 Consort	 and	 The	 School	 of	 Pharmacy	
2010)	attempted	to	link	medicines	wastage	with	loss	of	therapeutic	value	from	
medicines.	 	 The	use	of	medicines	was	 categorised	 then	as	 either	optimal	 (i.e.	
medicines	 are	 fully	 consumed,	 and	 therapeutic	 benefits	 maximised)	 or	





with	 estimates	 suggesting	 that	 the	 split	 between	 preventable	 and	 non-
preventable	 waste	 is	 roughly	 50:50	 (York	 Health	 Economics	 Consort	 and	 The	
School	of	Pharmacy	2010).			The	authors	suggested	that	reducing	the	avoidable	
waste	burden	would	 result	 in	 some	extra	 costs	 associated	with	 implementing	
better	waste	 control	measures.	 Even	 factoring	 this	 in,	 they	estimated	 that	on	


















Medicines taken / 
administered in 
accordance with the 
prescriber’s intentions 
and therapeutic benefits 
maximized
Therapeutic Loss
Medicines fully consumed 
(but not in line with 
prescriber’s intentions 
e.g. incorrect doses, 
irregular dosing intervals)   
Medicines taken / 
administered in such a 
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Intentional and Unintentional non-adherence













The	World	Health	Organisation	has	highlighted	 five	 factors	 that	contribute	 to	
non-adherence	(World	Health	Organization	2003)(see	Table	4.3).	Allemann	and	
colleagues	 suggested	 that	 these	 factors	 could	be	divided	 into	modifiable	 and	
non-modifiable	 determinants	 of	 non-adherence	 (Allemann	 et	 al.	 2016).	 For	
example,	 a	 patient’s	 knowledge	 and	 beliefs	 about	 their	 medicines	 may	 be	
modifiable	 through	 an	 educational	 intervention	 whilst	 their	 educational	
attainment	may	 be	 non-modifiable	 (at	 least	 in	 the	 short	 term).	 The	 authors	
suggested	 that	 in	 the	 main	 interventions	 should	 be	 directly	 targeted	 at	 the	













Socioeconomic	factors	 Poor	 educational	 attainment,	 unemployment,	 low	
socioeconomic	status	
Healthcare	systems	and	team	factors	 Ineffective	 medication	 distributions	 services,	
overworked	healthcare	professionals	
Therapy	related	factors	 The	 duration	 of	 treatment,	 how	 immediate	 the	














nursing	 home	 environment.	 The	 authors	 concluded	 that	 the	major	 theme	 to	
emerge	was	‘control’.	GPs	and	nurses	respectively	felt	it	was	necessary	to	retain	
control	of	prescribing	and	administration	 to	ensure	 the	safety	and	efficacy	of	
medicines.	 Residents	 apparently	 accepted	 this	 control	 without	 question,	
reported	that	they	were	adherent	to	their	medicines	and	were	not	involved	in	
share	 decision	 making	 (Hughes	 and	 Goldie	 2009).	 Although	 adherence	 to	
medicines	 in	 the	care	home	setting	could	be	described	as	optimal	due	to	the	
regimented	administration	of	medicines,	 there	 is	evidence	 in	the	 literature	of	
enforced	adherence	(compliance)	whereby	a	resident	continues	to	receive	their	
medicines	 for	 extended	 durations	 without	 review.	 This	 may	 exacerbate	 any	
adverse	 reactions	 to	 such	medicines	 	 (Hughes	2008).	 	 	Barnes	and	colleagues	






non-compliance”	 for	 example	where	 they	 had	 cognitive	 impairment	 or	were	
unable	 to	 communicate	 (Barnes	 et	 al.	 2006).	 	 This	 issue	 can	 be	 exacerbated	
where	covert	administration	occurs	i.e.	administrations	are	concealed	in	food	or	
drink.	Whilst	this	may	be	justified	on	medical	grounds,	there	are	instances	in	the	
literature	 where	 covert	 administration	 has	 occurred	 but	 is	 inappropriate	













cost	 for	 374	 items	 including	 solid	 dosage	 form	 (tablets,	 capsules),	 topical	











dose	 systems	was	 17%	 less	 than	 generated	 by	 traditional	 systems	 in	 a	 study	
conducted	 in	17	 care	homes	 in	 Indiana,	USA	 (Brown	and	Kirk	1984).	 This	was	
followed	by	another	study	in	1985,	to	estimate	the	cost	of	discarded	medicines	
in	 12	 nursing	 homes	over	 a	 two-year	 period.	 This	 study	 found	 that	 $64.08	 of	




by	 the	 York	 Health	 Economics	 Consortium	 in	 partnership	 with	 The	 School	 of	
Pharmacy,	London	(York	Health	Economics	Consort	and	The	School	of	Pharmacy	
2010).	They	studied	the	medicines	returned	to	114	community	pharmacies	over	
a	one-month	period.	 The	medicines	 returned	 from	care	homes	 accounted	 for	
16%	of	the	total	wastage	at	a	value	of	£50	million.	In	Wales,	medicines	waste	in	
care	 homes	 is	 under-explored	 although	 from	 a	 total	 of	 £98	million	 spent	 on	
prescribed	 medications	 in	 2016,	 £650,000	 were	 associated	 with	 unused	




























homes,	 the	 researcher	 noted	 a	 number	 of	 practices	 that	 suggest	 direct	 stock	
counts	are	more	appropriate	and	valid.	For	example,	medicines	were	found	 in	
the	home	that	had	been	stopped	i.e.	they	were	not	on	the	resident’s	MAR	chart,	
storage	 areas	 that	 were	 labeled	 with	 one	 resident’s	 name	 contained	 the	






The	 recruitment	of	 care	homes	 to	 this	 phase	of	 the	 study	was	 similar	 to	 that	
described	in	section	2.3.2	but	with	some	modifications.	Briefly,	care	homes	were	
recruited	 by	 purposive	 sampling	 from	 the	 ABMU	 health	 board	 in	Wales	 with	
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Social	 Inspectorate	 Wales	 (SIW)	 and	 currently	 use	 a	 paper-based	 MAR	 chart	


























11;	 and	 (vii)	 18	 February-care	home	14.	 Ideally,	 each	home	would	have	been	
visited	with	the	same	number	of	days	remaining	in	the	medicines	cycle.	However,	
this	was	not	possible	as	the	research	team	had	to	work	around	the	care	home’s	




A	 copy	 of	 the	MAR	 chart(s)	 for	 each	 of	 the	 residents	 was	 obtained	 and	 the	
quantity	of	medicine(s)	that	should	be	remaining	for	each	resident	to	the	end	of	
















each	 patient	 until	 the	 next	medication	 cycle	 started	with	 the	 actual	 quantity	





counts	 were	 entered	 directly	 into	 Microsoft	 Excel	 for	 Mac	 version	 15.33	
(Microsoft	Corporation;	Seattle,	USA).		














signature	 of	 the	 person	 responsible	 for	 entering	 the	 medicines	 returns	




used.	 In	two	of	 the	homes,	 the	stock	 in	the	returns	bins	was	cross-referenced	










Care	Home	 Returns	book	analysed	 Stock	counts	made	 Number	of	days	remaining	in	
medicines	cycle	
3	 January	meds	cycle	 17/3/2015	 8	days	
4	 April	meds	cycle	 20/3/2015	 3	days	
6	 Not	available		 10/3/2015	 15	days	
8	 Not	available	 18/2/2015	 5	days	
9	 January	meds	cycle	 18/2/2015	 5	days	
11	 January	meds	cycle	 18/2/2015	 5	days	
14	 Not	available	 18/2/2015	 5	days	
	
4.3.4 Data	analysis	
























Table	 4.5	 represents	 the	 value	 of	 overstock	 in	 the	 seven	 participating	 care	
homes.	As	can	be	seen,	the	total	value	of	overstock	was	£3119.95	which	equates	




















3	 Nursing	 25	 £451.25	 £18.05	
4	 Nursing	 29	 £130.68	 £4.50	
6	 Nursing	 27	 £746.41	 £27.64	
8	 Residential	 24	 £304.25	 £12.65	
9	 Nursing	 16	 £708.57	 £44.29	
11	 Nursing	 26	 £774.05	 £29.77	
14	 Residential	 7	 £4.74	 £0.68	





In	 order	 to	 understand	 the	 nature	 of	 the	 medicines	 waste	 generated,	 the	




13	categories	examined	each	contributed	more	 than	10%	of	 the	value	of	 the	
waste	generated	and	combined	they	accounted	for	more	than	70%	of	the	value	
of	the	waste	generated.	These	represented	medicines	that	act	on	the	GI	system	
(£605.19;	 19.40%),	 the	 cardiovascular	 system	 (£411.11;	 13.18%),	 the	nervous	
system	(£832.34;	26.68%)	and	medicines	used	in	infections	(£365.61;	11.72%).	
Very	little	waste	in	terms	of	value	(less	than	5%	of	the	total)	was	generated	by	
medicines	 acting	 on	 the	 genito-urinary	 system,	 medicines	 used	 for	 blood	
disorders	or	nutritional	issues,	medicines	used	for	musculo-skeletal	problems	or	
used	to	treat	eye	conditions.	No	waste	was	identified	for	medicines	used	to	treat	






























A	 breakdown	 of	 the	 individual	 medicines	 that	 were	 wasted	 in	 the	 four	
therapeutic	 areas	 where	 waste	 was	 highest	 (i.e.	 GI	 system,	 cardiovascular	
system,	nervous	system	and	medicines	used	to	treat	infections)	is	shown	in	Table	
4.7.	 As	 can	 be	 seen	 laxatives	 (£572.70)	 and	 paracetamol	 containing	 products	
(£253.67)	are	the	largest	contributors	to	the	total	value	of	waste	accumulated	
followed	closely	by	memantine	and	furosemide.	Unlike	memantine	which	has	a	
relatively	 high	 price	 (unit	 pack	 cost	 of	 £12.71),	 paracetamol,	 laxatives	 and		
furosemide	are	all	inexpensive	(unit	pack	costs	less	than	£10)	indicating	that	the	
volume	of	waste	associated	with	these	drugs	is	high.	Rifaximin	has	a	particularly	


















Opioid	analgesics	 Co-codamol	 £34	 4	
Anxiolytics	 Diazepam	 £15.98	 2	
Lorazepam	 £26.81	 3	








Dementia	 Memantine	 £226.97	 27	
Anti-Parkinsonian	 Madopar	 £13.68	 2	
	
Gastrointestinal	System	–	total	waste	=	£609.19	
Laxatives	 Lactulose	 £201.83	 33	
	 Macrogol	 £99.55	 16	
	 Senna	 £237.43	 39	
	 Movicol	 £33.89	 6	
PPIs	 Omeprazole	 £16.23	 3	
	
Cardiovascular	system	–	total	waste	=	£411.11	
Beta-blocker	 Bisoprolol	 £33.79	 8	
ACIs	 Lisinopril	 £10.69	 3	
	 Ramipril	 £8.79	 2	
AIIRA	 Losartan	 £75	 18	
Cardiac	glycoside	 Digoxin	 £15.81	 4	
Diuretics	 Furosemide	 £204.23	 50	



























medicines	 were	 relatively	 inexpensive	 and	 there	 were	 few	 instances	 of	
medications	with	a	relatively	high	unit	pack	cost	of	over	£50	being	wasted	(5.5%	
of	all	waste).	Of	course,	even	with	a	low	incidence	of	medicines	with	a	high	unit	
pack	 cost	 being	 wasted,	 if	 sufficient	 volume	 is	 wasted,	 this	 may	

















£0	<10	 165	 82.5%	 £1,424.96	 45.67%	
£10-25	 17	 8.5%	 £658.61	 21.11%	
£25-50	 7	 3.5%	 £388.65	 12.46%	
£50-100	 8	 4%	 £304.00	 9.74%	
£100+	 3	 1.5%	 £343.73	 11.02%	






the	 highest	 quantities	 of	 wasted	 medicines	 (in	 terms	 of	 dosage	 units)	 was	
examined	in	each	of	the	seven	care	homes;	the	data	is	presented	in	Table	4.9.	
As	 can	 be	 seen,	 in	 some	 care	 homes	 (4,	 8,	 9,	 11)	 there	 were	 examples	 of	
medicines	 where	 there	 were	 more	 than	 1,000	 dosage	 units	 overstocked	
although	in	terms	of	value	these	did	not	exceed	£100	of	waste.	Paracetamol	was	











of	 the	 seven	 homes.	 It	 is	 worth	 highlighting	 that	 analgesics,	 laxatives	 and	
benzodiazepines	are	normally	prescribed	on	a	when	required	basis.	A	surprising	



















































In	 addition	 to	 examining	 the	 medicines	 that	 were	 wasted	 in	 the	 highest	





quantity	 (Table	 4.9),	 paracetamol	 and	 laxatives	 are	 over	 represented	 with	
paracetamol	featuring	in	the	top	five	in	six	care	homes	and	laxatives	featuring	in	
















Levothyroxine	 £139.00		 30.80	 1	 180ml	
Furosemide	 £100.02	 22.17	 2	 480ml	
Losartan	 £51.00	 11.30	 1	 190ml	
Terbutaline	 £47.89	 10.61	 1	 692	doses	
Pericyazine	 £20.39	 4.52	 2	 (93	tab.+	17.5ml)	
Care	home	4	–	total	waste	=	£130.68	
Paracetamol		 £47.03	 35.99	 13	 1,057	tab.	
Macrogol	powder	 £25.73	 19.69	 3	 87	sachets	
Laxido	sachets	 £12.42	 9.50	 2	 42	sachets	
Senna	 £8.78	 6.72	 2	 74	tab.	
Co-codamol	 £7.11	 5.44	 3	 179	tab.	
Care	home	6	–	total	waste	=	£746.41	
Rifaximin	 £180.53	 24.19	 1	 39	tab.	
Nitrofurantoin	 £163.19	 21.86	 1	 250ml	
Pericyazine	 £91.27	 12.23	 2	 (95tab.+173.75ml)	
Paracetamol	 £33.65	 4.51	 14	 (898	tab.+670ml)	
Symbicort	 £31.66	 4.24	 1	 50	doses	
Care	home	8	–	total	waste	=	£304.25	
Symbicort	Inhaler	 £90.75	 29.83	 1	 330	doses	
Promazine	 £59.75	 19.64	 1	 755ml	
Paracetamol	 £46.03	 15.13	 20	 (1143tab.+1160ml)	
Laxido	sachets		 £43.29	 14.23	 3	 89	sachets	
Movicol		 £27.38	 9.00	 4	 123	sachets	
Care	home	9	–	total	waste	=	£708.57	
Memantine	tab.	 £220.65	 31.14	 4	 486	tab.	
Senna	 £170.41	 24.05	 5	 (236	tab.+1200ml)	
Fostair	Inhaler	 £85.52	 12.07	 1	 350	doses	
Paracetamol	 £37.65	 5.31	 7	 1178	tab.	
Stronium	sachets	 £30.95	 4.37	 1	 32	sachets	
Care	home	11	–	total	waste	=	£774.05	
Complan	shake		 £179.27	 23.16	 2	 122	sachets	
Seretide	Inhaler	 £114.00	 14.73	 1	 230	doses	
Paracetamol	 £72.44	 9.36	 15	 (2,043tab.+580ml)	
Laxido	sachets	 £65.94	 8.52	 4	 223	sachets	
Saline	2.5ml	 £58.71	 1.91	 1	 57	doses	
Care	home	14	–	total	waste	=	£4.74	
Paracetamol		 £3.09	 65.19	 2	 	 97	tab.	
Diazepam	2mg	tab	 £1.65	 34.81	 1	 48 tab.	
	
4.4.6 Medicines	 wasted	 characterised	 by	 whether	 the	 medicine	 was	
prescribed	with	regular	or	when	required	dosing	
The	findings	highlighted	in	Tables	4.9	and	4.10	suggested	that	wasted	medicines	








one	 care	 homes	 (care	 home	 11),	 in	 five	 care	 homes	 regular	 medicines	
contributed	more	to	the	total	waste	(care	homes	3,	6,	9	and	14)	whilst	in	one	
care	home	it	was	evenly	split	(care	home	8).	This	tendency	in	the	data	towards	
















3	 £427.01	 £24.24	 5.37%	 £451.25	
4	 £100.32	 £30.36	 23.23%	 £130.68	
6	 £434.36	 £312.04	 41.81%	 £746.40	
8	 £152.53	 £151.72	 49.87%	 £304.25	
9	 £533.83	 £174.74																																																		24.66%	 £708.57	
11	 £247.00	 £527.05	 68.09%	 £774.05	







4.12).	 The	 total	 value	 of	 the	 medicines	 returned	 from	 the	 four	 homes	 was	
£1780.64	 which	 equates	 to	 £18.54	 returned	 per	 month	 for	 each	 of	 the	 96	
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residents	 in	 the	 homes.	 This	 is	 remarkably	 similar	 to	 the	 estimated	 cost	 of	
medicines	 wasted	 using	 an	 audit	 of	 the	 overstock	 in	 the	 homes	 (£20.05	 per	
resident).	The	range	in	the	value	of	returned	medicines	was	from	£41.26	(care	
home	 4)	 to	 £792.53	 (care	 home	 11)	 with	 an	 average	 of	 £445.16	 (±	 £327.95)	














3	 Nursing	 25	 £336.96	 £13.49	
4	 Nursing	 29	 £41.26	 £1.42	
9	 Nursing	 16	 £609.89	 £42.63	
11	 Nursing	 26	 £792.53	 £27.25	





There	 have	 been	 numerous	 debates	 in	 the	 literature	 on	 the	 definitions	 of	
medicines	waste	and	at	what	point	 it	occurs.	Does	 it	occur	for	example	at	the	
point	 it	 is	 returned	to	a	pharmacy	or	when	 it	 is	destroyed	by	a	medical	waste	
contractor	 or	 does	 that	 fail	 to	 capture	 medicines	 that	 are	 destroyed	
inappropriately	 by	 individuals	 in	 their	 own	 homes	 or	 by	 staff	 in	 a	 healthcare	
setting.		Similarly,	the	literature	suggests	that	patients	and	staff	have	a	tendency	
to	stockpile	medicines	unnecessarily,	presumably	for	‘just	in	case’	scenarios	or	to	
be	 returned	 or	 destroyed	 at	 some	 point	 in	 the	 future.	 Together,	 these	
considerations	make	the	accurate	measurement	of	waste	challenging	and	most	











records	may	not	be	reliable.	As	a	consequence,	 it	 is	useful	 to	undertake	stock	
audits	to	understand	if	medicines	are	being	kept	in	the	home	inappropriately	in	




remaining	 (based	 on	 the	MAR	 chart)	was	 subtracted	 from	 the	 count	 and	 any	
remaining	 medicines	 for	 the	 resident	 was	 termed	 overstock.	 The	 medicines	
returns	 books	 from	 four	 homes	 were	 also	 analysed	 to	 calculate	 the	 value	 of	
medicines	returned	at	the	end	of	a	medicines	cycle.	Ideally,	it	would	have	been	










the	 resident’s	 name.	 However,	 in	 some	 homes,	 there	 was	 evidence	 of	












revealed	an	estimated	waste	medicines	bill	 of	 £18.54	per	 resident	per	month	










Health	Economics	Consort	and	The	School	of	Pharmacy	2010).	This	 is	 likely	 to	
underestimate	the	total	value	of	waste	medicines	from	care	homes	because	the	
study	 methodology	 only	 captured	 medicines	 returned	 to	 a	 pharmacy	 from	




















the	 end	 of	 the	medicines	 cycle),	 it	 better	 captures	 the	 totality	 of	 the	wasted	
medicines	because	it	accounts	for	any	stock	piling.	The	actual	value	of	the	waste	
counted	was	in	good	agreement	with	the	returns	book	with	£20.25	of	medicines	
waste	per	 resident	 (£3119.95	of	waste	 for	154	 residents).	 In	each	of	 the	 care	
homes	studied,	the	researcher	confirmed	that	medicines	had	been	returned	at	
the	 end	 of	 the	 previous	medicines	 cycle	 and	 therefore	 the	 accumulated	 over	




In	 line	with	 other	 studies,	 the	majority	 of	medicines	wasted	were	 reasonably	
inexpensive	with	82.5%	of	the	waste	having	a	unit	cost	that	was	less	than	£10.		
For	example,	in	the	seminal	York	study	(York	Health	Economics	Consort	and	The	













lead	 to	 high	 value	 waste.	 The	 first	 is	 the	 supply	 of	 three	 months	 worth	 of	







The	 most	 commonly	 wasted	 medicines	 in	 this	 study	 were	 paracetamol	 (and	








School	 of	 Pharmacy	 2010;	Herefordshire	 Clinical	 Commissioning	Group	 2015).		
The	same	is	true	of	 laxatives	 in	the	care	home	setting	(York	Health	Economics	
Consort	 and	 The	 School	 of	 Pharmacy	 2010).	 For	 example,	 paracetamol	 and	
paracetamol	containing	preparations	accounted	for	14.4%	of	all	medicines	waste	
in	the	York	study	and	laxatives	accounted	for	15.5%.	In	total,	these	two	groups	
accounted	 for	 ~	 30%	 of	 the	 medicines	 waste	 identified	 which	 is	 remarkably	






durations	when	 they	 are	 only	 required	 to	manage	 acute	 issues	 	 (York	 Health	
Economics	Consort	and	The	School	of	Pharmacy	2010).		
One	 common	 feature	 of	 laxatives	 and	paracetamol	 containing	 preparations	 is	
that	they	are	both	commonly	prescribed	on	an	‘as	required’	(PRN)	basis.	They	are	
then	sporadically	 required	by	 the	 residents	during	a	medicines	cycle,	but	care	


















are	 taken	by	 residents.	This	generally	has	 two	causes:	 (i)	 there	 is	 a	 significant	
patient	 event	during	 the	medicines	 cycle	 such	as	 a	death,	 hospital	 admission,	
change	in	a	medicine(s)	or	the	patient’s	condition	changes	to	the	extent	that	they	




patient	 consumption	 and	 repeat	 ordering.	 The	 first	 cause	 is	 reasonably	









examine	 the	 stock	before	 requesting	 the	new	monthly	 cycle,	 it	would	also	be	
appropriate	that	members	of	the	pharmacy	team	challenge	the	order	where	it	is	
evident	that	medicines	are	reordered	ad	infinitum.		
In	 the	 literature,	 a	 number	 of	 interventions	 have	 been	 suggested	 to	 reduce	
medicines	waste	 in	 care	homes	 (Roberts	 et	 al.	 2001;	Crotty	 2007;	 Koria	 et	 al.	
2018).	One	of	the	primary	mechanisms	is	through	the	use	of	regular	medicines	
reviews.	NICE	defines	medication	review	as:	“a	structured,	critical	examination	of	
a	 person’s	 medicines	 with	 the	 objective	 of	 reaching	 an	 agreement	 with	 the	
person	 about	 treatment,	 optimising	 the	 impact	 of	 medicines,	 minimising	 the	
number	of	medicationrelated	problems	and	reducing	waste”	(NICE	2015).	Such	
reviews	(undertaken	by	a	GP	or	pharmacist)	would	account	for	any	changes	in	
the	 resident’s	 management	 plan	 and	 would	 serve	 to	 optimise	 a	 resident’s	
pharmaceutical	 care	 (Duerden	M	2013;	 Royal	 Pharmaceutical	 Society	 England	
2016).	 Not	 only	 does	 this	 medicines	 optimisation	 improve	 health	 outcomes	
(Royal	Pharmaceutical	Society	Wales	2016)	and	resident	safety	(Welsh	Medicines	
Resource	 Centre	 2016),	 as	 a	 by-product	 there	 is	 evidence	 that	 it	 leads	 to	
reduction	in	medicines	waste	(Crotty	2007).			
Another	area	where	interventions	can	be	targeted	is	through	the	continuous	and	









resident’s	 beliefs	 about	 their	medicines	 and	 to	 subsequently	 develop	 tailored	







of	 the	 processes	 in	 place	 for	 managing	 waste.	 The	 CQC	 and	 analogous	
organisation	 have	 set	 out	 clear	 requirements	 for	 the	medicines	management	
process	that	includes	standards	related	to	the	documentary	trail	of	medicines	in	
the	 home,	 from	 receipt	 on	 arrival,	 administration	 and	 return	 or	 disposal.	
However,	there	was	evidence	that	such	practices	are	not	universally	adopted	or	
embedded.	 Developing	 care	 home	 staff	 to	 better	 manage	 waste	 would	 be	 a	
priority	 area	 for	 attention.	 Similarly,	 better	 interprofessional	 co-operation	
(between	the	prescriber,	pharmacist	and	care	home)	on	prescribing	and	repeat	
dispensing	 would	 help	 to	 bring	 medicines	 waste	 down.	 For	 example,	 if	 the	
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investment	 made	 60	 years	 ago	 (Institute	 for	 Fiscal	 Studies	 2018).	 Even	
accounting	for	inflation	rises,	this	represents	an	incredible	increase	in	spending.	




Blunt	 2015).	 	 An	 ageing	 population	 contributes	 to	 these	 problems.	 Life	




likely	 to	 have	 chronic	 conditions	 such	 as	 cardiovascular	 disease,	 respiratory	
disease,	cognitive	impairments	(particularly	dementia)	and	cancer	(Nihtilä	et	al.	















in	 secondary	 care	 is	 the	 shrinking	 spend	 on	 council-lead	 social	 care	 that	 has	
squeezed	domiciliary	care.	In	the	face	of	a	rising	population	of	older	adults,	the	
number	 receiving	 state	 social	 care	 has	 fallen	 by	 25%	 in	 the	 last	 four	 years	
(Cromarty	2018).	Of	note	the	healthcare	budget	for	2017/18	was	over	five	times	
that	 of	 the	 social	 care	 budget	 (£110bn	 vs	 20.8bn)(THE	 UK’S	 INDEPENDENT	
FACTCHECKING	CHARITY	2018).	This	shifts	people	towards	the	secondary	care	
environment	when	policy	is	to	keep	people	in	primary	care	for	as	long	as	possible	
















required.	 Nursing	 homes	 which	 provide	 round	 the	 clock	 nursing	 care	 would	



















home	 group	 that	 had	 750	 homes.	 Accountancy	 firm	 Moore	 Stephens	 have	
estimated	that	12%	of	all	care	homes	have	a	30%	or	greater	risk	of	bankruptcy	
within	 the	 next	 three	 years	 (Stephens	 2016).	 This	 is	 as	 a	 consequence	 of	 a	
number	of	factors	including	a	31%	(£4.1bn)	reduction	in	local	authority	/	council	
funding,	a	cap	on	an	individual’s	contribution	to	their	care,	the	introduction	of	
the	 national	 living	 wage	 and	 the	 introduction	 of	 automatic	 state	 pension	
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is	 partly	 as	 a	 consequence	 of	 improved	 access	 to	 resources	 and	 the	 multi-
disciplinary	environment	in	such	settings	that	is	deficient	in	the	care	home	sector	
(Dilles	et	al.	2011).	 In	addition,	 there	 is	a	shortage	of	experienced	care	home	
managers	with	estimates	suggesting	 that	 some	care	homes	operate	 for	years	




A	 further	 pressure	 on	 the	 sector	 is	 increased	 regulatory	 scrutiny	 as	 a	
consequence	 of	 a	 number	 of	 significant	 incidents	 in	 the	 care	 home	 setting	
(Phelan	2015;	Manthorpe	and	Martineau	2016).	This	scrutiny	is	understandable	




has	 a	 range	 of	 powers	 up	 to	 and	 including	 the	 ability	 to	 revoke	 the	 home’s	
registration.	Even	where	it	chooses	not	to	do	so,	a	sub-standard	rating	is	likely	





















etc.	 for	 each	 resident.	 This	 data	was	 then	used	 to	 identify	 the	prevalence	of	
polypharmacy	 (more	 than	 five	 medicines	 prescribed)	 and	 excessive	

















the	 resident	 directly	 but	 rather	 receive	 information	 related	 to	 the	 resident	
second-hand	via	the	nurse	or	carer	(Bergman	et	al.	2007).		
In	common	with	other	studies,	a	significant	number	of	residents	were	prescribed	
proton	 pump	 inhibitors	 (McDonald	 et	 al.	 2015;	 Rane	 et	 al.	 2017)	 and	
psychotropic	medicines	(Ruggiero	et	al.	2010;	Shah	et	al.	2012;	Beers	et	al.	1988;	





et	al.	2015).	 	 In	a	population	that	 is	susceptible	to	falls	(Ding	et	al.	2014),	the	
increased	 risk	of	 fractures	 is	particularly	problematic.	Psychotropic	medicines	
use	in	older	adults	is	similarly	problematic.	Many	care	home	residents	have	some	
degree	 of	 cognitive	 impairment	 and	 the	 inappropriate	 use	 of	 antipsychotics,	







These	 medicines	 were	 generally	 prescribed	 on	 a	 use	 ‘when	 required’	 basis.	
Whilst	 the	 risk	 of	 harm	 from	 such	 agents	 is	 much	 lower	 than	 for	 PPIs	 and	
psychotropic	agents,	there	is	a	tendency	to	prescribe	such	medicines	chronically	
rather	 than	 to	 treat	 acute	 conditions.	 	 Of	 note,	 in	 line	 with	 other	 studies	
(Darracott	and	Johnstone	2012;	York	Health	Economics	Consort	and	The	School	
of	 Pharmacy	 2010;	 Herefordshire	 Clinical	 Commissioning	 Group	 2015)	 in	
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been	 developed	 that	 seek	 to	 categorise	 such	 inappropriate	 prescribing.	 Such	
criteria	are	either	explicit	(a	list	of	medicines	to	be	avoided	or	used	with	caution)	




were	prescribed	a	medicine	 that	 should	be	 avoided	or	used	with	 caution.	Of	
note,	60%	of	residents	received	at	least	one	medicine	that	should	be	avoided.	
Much	like	polypharmacy	this	 is	 likely	a	consequence	of	 infrequent	review	and	
optimisation	of	medicines	in	the	care	home	setting	(Spinewine	et	al.	2007;	De	
Smet	et	al.	2007).		
More	 recently,	 there	 has	 been	 a	 growing	 concern	 on	 the	 use	 of	 drugs	 with	
anticholinergic	properties	in	older	adults	(Chatterjee	et	al.	2017;	Pfistermeister	
et	 al.	 2017).	 Increased	 anticholinergic	 burden	 is	 associated	 with	 dementia,	
cognitive	 impairment,	 falls	 and	 increased	 risk	 of	 mortality	 	 (Fox	 et	 al.	 2011)	
(Marcum	 et	 al.	 2015;	 Naja	 et	 al.	 2016;	 Chatterjee	 et	 al.	 2017).	 	 Using	 the	
Anticholinergic	Effect	on	Cognition	scoring	system,	the	anticholinergic	burden	
was	 calculated	 for	 each	 resident	 in	 the	 study	 population.	 	 Some	 11.9%	 (31	
residents)	of	all	residents	accrued	an	anticholinergic	score	of	three	or	four	which	
is	thought	to	be	clinically	relevant	and	4.2%	(11	residents)	a	score	of	five	or	more	

















any	 protocols	within	 the	 literature	 to	 characterise	 errors	 on	MAR	 charts	 and	








administration	 errors	 arise	 as	 a	 consequence	 of	 a	 range	 of	 factors	 including	















be	 appropriate	 for	 the	 individual	 to	make	 such	 a	 judgement.	 Similarly,	 there	
were	examples	of	medicines	being	duplicated	on	the	MAR	chart	which	risks	a	
patient	 receiving	 an	 overdose	 of	 their	 medicine(s).	 One	 of	 the	 contributory	
factors	 leading	 to	 this	 is	 a	 lack	of	 interprofessional	 co-operation	 (Dilles	 et	 al.	
2011;	 Baylis	 and	 Perks-Baker	 2017).	 These	 types	 of	 issues	 are	 everybody’s	






































that	 have	 sought	 to	 estimate	 the	 scale	 of	waste	 in	 care	 homes	 (Caswell	 and	
Cleverley	 1983;	 Brown	 and	 Kirk	 1984;	 Farmer,	 R	 G.	 et	 al.	 1985).	 	 Given	 a	
residential	 care	 home	 stay	 costs	 ~£600	 per	 week,	 this	 equates	 to	 150,000	
resident	weeks	 lost	 to	waste	medicines.	Whilst	 a	 proportion	 of	 this	waste	 is	
unavoidable,	for	example	when	a	patient	dies	or	when	there	is	an	appropriate	
change	 in	 a	 patient’s	 medication	 regimen	 as	 a	 result	 of	 a	 change	 in	 their	
condition	or	due	to	an	adverse	drug	reaction,	there	is	evidence	that	a	significant	
volume	of	waste	could	be	avoided	(West	2015).	In	care	homes,	this	is	normally	
associated	with	 poor	 prescribing,	 ordering	 and	 dispensing	 processes	 that	 are	




when	 this	 is	 unnecessary	 because	 a	 patient	 or	 resident	 has	 accumulated	
medicines	due	to	a	break	in	their	last	medicines	cycle	(Birchall	2016).		
Of	note,	 a	 significant	 volume	of	 the	waste	both	 in	 terms	of	 the	dosage	units	
wasted	 and	 the	 value	 of	 the	 waste	 was	 associated	 with	 laxatives	 and	
paracetamol	 containing	 products	 (accounting	 for	 27%	 of	 all	 the	 waste	
generated).	 Again,	 extrapolating	 to	 the	 UK	 care	 home	 population,	 this	
represents	a	potential	waste	of	approximately	£4M	per	annum.	As	was	seen	in	
Chapter	2,	the	prescribing	of	such	products	which	should	be	on	an	acute	basis	is	




One	 theory	 that	 continues	 to	 be	 promoted	 in	 some	 circles	 is	 that	medicines	







a	pack	 cost	of	 (£259.23)	 contributed	5.7%	of	 the	 total	waste	and	24%	of	 the	
waste	in	the	home	in	which	its	as	generated.		
Whilst	 the	 process	 of	 incremental	 gains	 (every	 little	 helps)	 is	 a	 valuable	
approach,	 if	 the	 sector	 is	 to	 tackle	 the	 problem	 of	 waste	 medicines	 in	 care	
homes,	a	rethink	of	the	system	is	needed.	The	system	for	reordering,	prescribing	







intensive	and	given	 the	 staff	 and	workload	pressures	 (Kavanagh	2017)in	 care	
homes	this	approach	is	unrealistic.	The	digital	enablement	of	care	homes,	and	
more	broadly	the	healthcare	sector	(Maguire	et	al.	2018),	is	on	the	horizon	and	
a	 number	 eMAR	 	 systems	 (Redley	 and	 Botti	 2013)	 are	 in	 development	 that	
include	 automated	 stock	 ordering	 	 based	 on	 current	 holdings	 of	 medicines.	
However,	GP	prescribing	systems	are	generally	not	connected	to	such	systems	
and	are	designed	to	generate	prescriptions	in	multiples	of	28	days.	Any	deviation	
from	 such	 an	 approach	 generally	 needs	 manual	 intervention.	 Ultimately,	
addressing	avoidable	medicines	waste	in	care	homes	is	a	priority	and	would	free	
up	resources	both	financial	and	human	to	better	support	resident	care.		
One	 of	 the	 primary	 issues	 related	 to	medicines	 in	 care	 homes	 is	 the	 lack	 of	
recognition	that	it	is	a	problem.	Indeed,	in	a	recent	study	to	identify	the	research	
priorities	in	care	home,	not	one	of	the	15	research	priorities	identified	featured	
medicines	 (Shepherd	 et	 al.	 2017).	 However,	 the	 priorities	 did	 include	 for	
example	 “What	 is	 the	public	 and	media	perception	of	 care	homes	 compared	
with	other	care	settings,	and	what	is	the	impact	on	care	home	staff	attitudes?”.	
This	is	by	no	means	a	criticism,	these	priorities	were	generated	within	the	sector	







A	confounding	 factor	 is	 that	 it	 is	difficult	 for	 regulators	 to	monitor	medicines	
management	 performance	 in	 homes.	 Despite	 regulatory	 standards	 for	
medicines	 management	 (Welsh	 Assembly	 Government	 2004;	 Royal	
Pharmaceutical	Soceity	of	Great	Britain	2007),	the	MAR	chart	remains	one	of	the	
few	 sources	 of	 evidence	 in	 the	 home	 that	 provides	 some	 indication	 of	 the	
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standard	 of	medicines	management.	 The	 researcher	 can	 personally	 evidence	
how	 challenging	 and	 resource	 intensive	 it	 is	 to	 analyse	 MAR	 charts	 and	
realistically	 it	 needs	 to	 be	 carried	 out	 by	 a	 healthcare	 professional	 with	 a	
background	 in	medicines	 use	 (pharmacist,	 physician	 etc).	 If	 regulators	 are	 to	
better	 understand	 the	 issues	 of	 medicines	 management	 in	 care	 homes	 it	 is	





home	setting	does	not	allow	 for	 ready	access	 to	patient	data	particularly	 the	
resident’s	 diagnoses.	 This	 data	 would	 have	 been	 particularly	 useful	 when	
assessing	potentially	inappropriate	prescribing	as	it	would	have	allowed	for	the	
use	 of	 a	 wider	 range	 of	 tools	 that	 require	 diagnostic	 information.	 As	 a	
consequence	the	study	employed	an	explicit	criteria	(Beers)	to	mitigate	against	
this.	Even	in	using	Beers	it	would	have	helpful	to	have	diagnostic	information	as	
an	 assessment	 could	 have	 been	 made	 as	 to	 whether	 the	 medicine(s)	 was	
appropriate	 given	 the	 condition.	 Lack	 of	 diagnostic	 data	 also	 made	 the	
measurement	 of	 potentially	 appropriate	 omissions	 impractical.	 For	 example,	
where	a	resident’s	vital	signs,	clinical	condition	or	biochemical	markers	indicate	












this	 study	 as	 it	 is	 UK	 based.	 However,	 the	 use	 of	 the	 global	 coding	 system		
‘anatomical-technical-chemical’	coding	(ATC)	which	was	developed	by	the	WHO	









understand	 the	 impact	 of	 medication	 errors	 on	 clinical	 health	 outcomes	 in	
residents.	An	important	consideration	here	would	be	assessing	residents	against	




In	 conclusion,	 the	 results	 described	 in	 this	 thesis	 have	 explored	 issues	
surrounding	medicines	prescribing,	administration	and	waste	in	the	care	home	
setting.	Although	not	explicitly	tested,	the	issues	identified	have	the	potential	to	
result	 in	resident	harm	and	will	 likely	 further	constrain	health	and	social	care	
resources.	 	 Residents	 of	 care	 homes	 represent	 a	 particularly	 vulnerable	
population	 and	 efforts	 should	 be	 renewed	 to	 enhance	 or	 embed	 a	
multidisciplinary	 approach	 to	 the	 health	 and	 social	 care	 of	 such	 residents.	
Currently,	the	system	does	not	enable	practitioners	to	effectively	collaborate	on	
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1.10	Ordering	medicines	 Care	home	providers	should	ensure	that	care	home	staff	 (registered	nurses	and	social	care	practitioners	working	 in	care	
homes)	have	protected	time	to	order	medicines	and	check	medicines	delivered	to	the	home.	


























	 1.14.11	 Care	 home	 staff	must	 record	medicines	 administration,	 including	 the	date	 and	 time,	 on	 the	 relevant	medicines	
administration	record,	as	soon	as	possible	and	ensure	that	they:	(i)	make	the	record	only	when	the	resident	has	taken	their	































































1. For	 analgesics,	 this	 class	 of	 drugs	 represents	 the	 majority	 of	 medicines	
administered	 in	 care	 homes	 particularly,	 Paracetamol	
and	Paracetamol	 containing	product.	 If	 the	product	was	written	as	a	 regular	
treatment,	the	counting	was	according	to	the	actual	administration	since	the	
staff	didn’t	follow	the	instruction	and	offered	it	according	to	the	resident	need	
and	most	 boxes	were	 filled	with	 codes	 referred	 to	 (offered	 not	 required	 or	
refusal)	therefore	all	these	boxes	were	excluded.		
2. Antibiotics,	 with	 this	 class	 of	 drugs,	 the	 administration	 was	 for	 short	 term	
course	and	in	some	cases,	they	didn’t	specify	the	time	to	complete	the	course,	







5. For	 medication	 with	 no	 entry,	 the	 counting	 was	 similar	 to	 the	 theoretical	
administration	depending	on	the	instructions.	
6. For	 medicines	 with	 unclear	 instructions	 about	 the	 frequency	 of	
administration	like:	“take	up	to	three	times	a	day”,	it	was	counted	according	to	
the	actual	administration.	






2-	 Any	 treatment	 discontinued	 during	 the	 cycle,	 the	 counting	 was	 for	 the	
actual	administration	not	theoretical.	













































































• Results	 indicate	 that	 medicines	 returned	 to	 the	 pharmacy	 may	 under-estimate	 the	
amount	 of	 waste	 and	 that	 there	 is	 a	 tendency	 to	 overstock	 medicines	 which	 may	
contribute	to	patient	harm	and	avoidable	waste.		
Introduction:	It	is	estimated	that	£50	million	worth	of	medicines	are	wasted	in	Wales	each	year1.	
One	 study	 found	 that	 wasted	medicines	 in	 care	 homes	 (CHs)	 accounts	 for	 16%	 of	 the	 total	
medicines	wastage	and	that	50%	of	wasted	medicines	can	be	avoided2.	The	cause	of	medicines	
waste	 in	 CHs	 is	 multifactorial	 and	 accurately	 quantifying	 such	 waste	 is	 methodologically	
challenging.	 It	 is	 recognised	 that	 using	 data	 from	 returns	 logs	 alone	 provides	 an	 incomplete	
picture.	 The	 aim	 of	 this	 study	 was	 to	 quantify	 medicines	 waste	 utilising	 two	 different	






the	 next	 medication	 cycle.	 A	 physical	 count	 of	 stock	 was	 conducted	 by	 the	 researcher	 to	
determine	 the	 quantity	 of	 overstock.	 A	 standardised	 protocol	was	 developed	 for	 calculating	
overstock	for	all	formulations	including		solid	dosage	froms,	those	in	liquid	form,	dermatological	















these	 data.	 For	 example,	 the	 two	 methods	 were	 conducted	 at	 different	 time	 points,	 and	
































Purpose:	 The	purpose	of	 this	 study	was	 to	 identify	 the	administration	errors	associated	with	
Beers	Criteria	medications	in	Care	Homes	






Results:	 Some	 82,817	 medicines	 administrations	 were	 analysed	 and	 a	 total	 of	 6770	
administration	errors	were	identified	for	all	medications	representing	an	error	rate	of	8.2%.	Of	





pharmacists	 as	 experts	 in	 medicines	 can	 play	 an	 active	 role	 in	 addressing	 medicines	
administration	issues	in	care	homes	to	reduce	the	risk	of	medicines	related	harm.	
References:	 Wiley	 Online	 Library.	 (2016).	 American	 Geriatric	 Society	 2015	 Updated	 Beers	
Criteria	 for	 Potentially	 Inappropriate	 Medication	 Use	 in	 Older	 Adults.	 [online]	 Available	 at:	
http://onlinelibrary.wiley.com/doi/10.1111/jgs.13702/pdf	[Accessed	2	Apr.	2018].	
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Appendix	3	–	MAR	chart	analysis	rulebook		
PRN rules in Blue 
AS DIRECTED rules in pink 
PRN 
Structured PRN (e.g. Take ONE four times a day when required) should show record of given or 
offered/refused.  Blank box = yes (error) ­ cannot assess ­ cannot assess PER blank box 
Unstructured PRN (e.g. take ONE when required) Blank Boxes = Cannot be judged ­ cannot 
assess­ cannot assess PER med.   
REGULATORY ERRORS 
. Any dose/form/strength hand amendments require TWO signatures  
. Changes mid­month need to be stopped (TWO signatures) and a new entry written (2 
signatures) 
. Pulse left blank = error if nursing home. Hand written signature required 
. Everything handwritten entry requires TWO signatures. 
. Discontinued requires TWO signatures. 
. Abx course completed requires ONE signatures. 
. Abx stopped required TWO signatures.   
. Clarification of instructions requires ONE signature. 
. Defined code required. Error PER DRUG undefined code. (NOT per entry) 
. If “C” is recorded for a dose, a carer administered the dose and this is not an error.   
. Variable doses, if dose on label is 1­2 tablets or 10­15ml, doses given on specific 
administrations should be clear, if not its an ERROR = missing chart information.   
. CD witness signature missing ­ error per dose given. 
. Apply as directed ­ 2 errors (As directed written AND incomplete dosage instructions 
RISK) 
. As directed (on its own) ­ 2 errors (As directed written AND dose missing.) 
. If its as directed, NOT an error if the time isn’t written but dose is required. 
.  As directed is an error by default. 
. Food “as directed” still an error. 
. Unstructured PRN requires MAX PRN, regardless of whether it is GTN spray, inhaler 
. Topical (creams/ointments etc.) PRN do not need max PRN 
. Structured PRN does not require max PRN as daily dose given.   
. Handwritten times for prn fine – alterations to regulars require a signature. 
 
ADMINISTRATION ERRORS 
. Crossed out signature no explanation – error (scribble) 
. If a scribble has been corrected underneath with the correct code, this is NOT an error.   
. One error PER omission and per PER deviation from dose 
. Omission = Doses missing 
. Deviation from stated dose = Extra doses given 
. “AS DIRECTED” meds are not assessed for omissions ­ can’t tell if they’ve been 
directed not to give 
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RISK ERRORS 
. Apply as directed ­ 2 errors (As directed written AND incomplete dosage instructions 
RISK) 
. As directed (on its own) ­ 2 errors (As directed written AND dose missing RISK) 
. Absent dose / form / strength are 3 separate errors. 
. Time missing in prn is a risk ERROR (missing time).  
. Time not required for as directed because you assume that they know how often to 
take it. 
. “Read leaflet” – error (incomplete dosage information) 
. Anything with “Space doses evenly” on label where doses have not been administered 
evenly = error (Deviation from stated dose) 
. Creams and ointments require site of application and frequency. 
. “Apply to affected area/eye” is error­Incomplete dosage information. 
 
STOCK ERRORS 
. Stock not received but given / stock quantity mismatch = error 
. Existing medication can be “carried forward” 
. Quantity of meds must be booked in but is not required on label. 
. N/A in signature box error (No sig) 
. 0g in quantity = 1 error each no sig and no date. 
. If quantity is “0” and it has been signed, if the chart is empty there is no error. 
 
CANNOT BE ASSESSED 
. ½ hour before/after food cannot be judged and cannot be assessed ­ unsure of exact 
meal/drug round completion. 
.  “At night” dose given at 5pm cannot be judged due to patient individual bedtimes. 
. Drainage bags treat like other meds 
 
OTHER POINTS OF NOTE 
.  Care homes will be numbered 
.  2 individual entries of same drug are counted as 1 drug 
.  2 formulations are 2 separate medications. 
. Chart errors vs medication errors. 
. Patients given their own medication is handled the same as the others. 
.   “Space doses evenly” absent NOT an error.  
. BD/TDS/QDS individual judgement as to time intervals. 
. Schedule 2 & 3 drugs counted as CDs. 
. Creams and QOL? 
. Dressings are treated as medications – ANALYSIS POINT 
 
 
 
